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Abstract 
 
Over the last few decades the use of pharmaceuticals has increased to a high level.  Used by 
both humans and animals, pharmaceutical active compounds (PACs) are not completely 
metabolised inside their bodies.  Consequently, PACs are excreted through urine or faeces and 
together, with the products of metabolisation, they enter wastewaters as biologically active 
substances.  Pharmaceuticals form a large group of compounds that are often polar molecules, 
therefore, are usually soluble in water.  Thus, many PACS cannot be completely removed from 
wastewaters; hence, are found globally in a wide range of environmental samples including: 
sewage treatment plant effluents, surface, ground and even in drinking water.  
The amounts of PACs detected in the environment are usually very low; they are often 
detected in trace concentrations (ng/L).  However, the long-term discharge of PACS may cause 
potential risk to both aquatic and terrestrial organisms.  Therefore, this research focuses on 
the removal of the common analgesics; acetaminophen and ibuprofen using zeolites as the 
absorbent.  Zeolites have attracted great attention as they are affordable materials that can be 
modified so to adjust or even tailor their adsorptive possibilities.  The zeolites clinoptilolite and 
beta (BEA) were used as the absorbents and were ion-exchanged with Cu(II), Fe(III) and NH4
+ 
ions, with the aim of removing acetaminophen and ibuprofen from water.  IR, XRD, HPLC and 
BET experiments were performed to measure uptake of the pharmaceuticals.  It was found 
that both zeolites were able to adsorb the pharmaceuticals in question, however, HPLC results 
showed clinoptilolite to be the better adsorbent.  The best uptake was exhibited by Cu-
exchanged clinoptilolite with the highest adsorption affinity towards ibuprofen.  It is believed 
that ibuprofen degraded during the adsorption experiments to produce ions that form stable 
complexes with the cations. 
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Chapter 1: Introduction  
 
1.1 Introduction  
 
Pharmaceutical products have increased both the quality of life and life expectancy across the 
globe.   In the last decade, low traces of pharmaceuticals, typically at levels in the ng/L have 
been detected in the environment [1].  The presence of pharmaceutical substances in water 
has raised concerns among stakeholders, such as drinking-water regulators, governments, 
water suppliers and the public.  In the long term, pharmaceuticals in the aquatic environment 
may cause potential risk towards both aquatic and terrestrial organisms.  Moreover, 
continuous discharge of pharmaceuticals may have physiological effects on humans and 
animals even in very low (trace) concentrations.  It has been proven that pharmaceuticals in 
the environment are persistent or pseudo-persistent [2,3] and toxic to organisms [4,5,6].  They 
also have the potential for bioaccumulation in organisms of different trophic levels [7,8], 
causing aquatic toxicity, development of resistance in pathogenic microbes, genotoxicity and 
endocrine disruption [9,10,11,12].  Therefore, pharmaceutically active compounds (PACs) are 
classified as ‘‘contaminants of emerging concern’’ (CECs), [9] or ‘‘emerging pollutants’’ (EPs).  
Although these chemicals have been released into the environment since they first started 
production, they have only been recently discovered in the environment [13] becoming an 
important threat to wildlife and also creating problems for the drinking water industry.   
Pharmaceuticals form a large group of synthetic or natural compounds used in human and 
veterinary medicine, as well as, aquaculture and agricultural products.  They are not 
necessarily a class of substances, as they have no chemical, physical, structural or biological 
similarities connecting them, meaning there is no overall class of chemicals that 
pharmaceuticals can be ordered into.  However, the large quantities produced and used has 
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led to the continual release of a wide array of pharmaceutical chemicals into our environment.  
Often being polar molecules, PACs are usually soluble in water.  Therefore, many PACs cannot 
be completely removed from wastewaters and as a result they can be found in a wide range of 
environmental samples including the sewage treatment plant effluents [9,14,15], ground and 
even drinking water, all over the world [16, 17, 18, 19].   
PACs in humans and animal drugs are not completely metabolised inside their bodies. 
Consequently, PACs are excreted through urine or feaces and together with their metabolites 
enter into wastewaters as biologically active substances.  Therefore, PACs in water sources and 
drinking-water are often present at trace concentrations.  Also, PACs are released during 
manufacturing, as well as by disposal of unused or expired drugs [9,10,20].   
The main sources of waste from pharmaceutical and personal care products are prescription 
and over-the-counter drugs, fragrances, cosmetics, veterinary drugs and vitamin supplements.  
Humans are exposed to these PACs through their drinking water or from bioaccumulation in 
the food chain.  As illustrated in figure 1.1, sources and pathways have been well identified, 
with the main route of release from human and animal excretion.  Hospitals play a large 
contributing factor as their sewage effluents and medical waste include a large array of 
different PACs.  Pharmaceuticals can also enter the environment through wastewater effluent, 
treated sewage sludge, industrial waste, medical waste from health-care and veterinary 
facilities, landfill leachate and biosolids [21].   
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Figure 1.1 – A diagram showing the concentrations detected for PACs in different parts of the 
environment [22]
 
Regulations regarding pharmaceutical residues in the environment are quite limited in spite 
there being several good procedures in place.  Following the European Guidelines, the 
Environmental Risk Assessment (ERA) of pharmaceuticals can identify “substances of concern” 
before market authorisation, but, this procedure is not applied to “old” pharmaceuticals 
already in use.   Even with the gaps in the ERA legislations identified, they still have not 
addressed issues in other legislations, such as the Groundwater Directive, relating to 
antimicrobial resistance in the environment.    
In 2008, the European Commission recognised that pharmaceutical residues are polluting 
waters and soils and this is seen as an emerging environmental problem and a public health 
concern.  Then in another communication in 2011, the European Commission proposed an 
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action plan against the rising threats from antimicrobial resistance.  It was also noted in the 
communication that the antimicrobials polluting the environment are contributing to the 
acceleration of the emergence and spread of resistant microorganisms.  
In 2012, on the basis of data regarding risks to the aquatic environment, particularly to fish, 
the commission proposed the inclusion of three pharmaceutical substances, 17-alpha 
ethinylestradiol, 17-beta estradiol and diclofenac, in the list of Priority Substances under the 
Water Framework Directive, but on a special “watch list”, meaning they will be monitored but 
not yet have an Environmental Quality Standard (EQS) set for them.  The European 
Commission has also committed to developing a strategic approach on pharmaceuticals in the 
environment.  This might include legislative and non-legislative solutions, such as development 
of improved source-control approaches and end-of-pipe solutions, and improved data-sharing 
to ensure a consistent basis for ERA [23]. 
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1.2 Occurrence of Pharmaceuticals 
 
The worldwide pharmacopeia has approximately 3500 pharmaceutical molecules listed and 
over 10% of these compounds have been detected in aquatic and terrestrial environments.  
With this being said, there is no routine monitoring programmes to test drinking water for 
pharmaceuticals.  Generally, data collected are from ad hoc surveys or targeted research 
projects.  Data collected show that pharmaceuticals have mainly been detected and measured 
in surface water [24,25,26] and wastewater effluents [27,28,29,30], ground water, marine 
water, drinking water [31,32,33,34,35], biosolids [36.37], sediments [38,39], soils [40,41,42] 
and biota [22,43,44,45].   
Antibiotics and anti-inflammatories have been measured and detected in sewage treatment 
effluents and surface waters worldwide.  In general, results gathered show that PACs 
belonging to this therapeutic class are present, more than 40% of the time, in collected 
samples with concentrations for half of them <0.1 μgL-1.  Ibuprofen, carbamazepine, diclofenac 
and sulfamethoxzole are the PACs detected in effluents at the highest concentration, as they 
are sold in highest quantities.  In fact, they have been measured and recorded in water 
samples from around 70% of the different countries where water has been sample [46].  
Whereas, acetylsalicylic acid has been detected at much lower concentrations compared to 
salicylic acid in the aquatic environment.  This is because salicylic acid is the degradation 
product from a number of compounds, including acetylsalicylic acid [22,47].  
Other analgesics and anti-inflammatories at lower concentrations have been detected in 
sewage effluents samples, surface waters, ground water samples and drinking water samples.  
PACs such as fenoprofen, indomethacin, ketoprofen and phenazone [48,49,50,51,52] have 
been detected in both sewage effluents sample and surface water samples.  Whilst, diclofenac, 
dimethylaminophenazone, phenazone and propyphenazone were detected in groundwater 
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samples [53,54,55,56,57,58].  However, in drinking water analgesics and anti-inflammatories 
measured were not detected above the limits of detection [59,60,61]. 
1.3 Advances in Analytical and Detection Methods 
There has been a continuous improvement in analytical techniques over the last decade.  The 
improvements allow for the identification and quantification of a broad range of substances at 
concentrations levels as low as ng/L.  In recent years, it has become possible to simultaneously 
analyse 3 times the number of compounds, increasing from around 30 compounds per 
analysis, to around 80-100 compounds [22]. 
The increase in reported detections of very low concentrations of pharmaceuticals in water is 
mainly attributable to technological advances.  Analytical instruments such as Gas 
Chromatography (GC) have had major improvements in both sensitivity and accuracy, allowing 
us to determine target compounds in the ng/L. GC with mass spectrometry (GC-MS) or tandem 
mass spectrometry (GC-MS/MS) and liquid chromatography with mass spectrometry (LC-MS) 
or tandem mass spectrometry (LC-MS/MS) are commonly used analytical instruments for the 
detection of pharmaceutical compounds in water and wastewater.   The method and 
instrument used is dependent on the physical and chemical properties of the target 
compound.  For example, LC-MS/MS analysis is more suitable for measuring target compounds 
that are more polar and highly soluble in water, whereas GC-MS/MS is better for more volatile 
target compounds [62].   
With improved analytical detection methods and instruments, we are able to learn more about 
the fate and occurrence of pharmaceuticals in the environment, including the water cycle.  
However, it is important to recognise that detection of these compounds does not directly 
correlate to human health risks, as the risks would have to be verified by available human risk 
assessment methods. In addition, there is currently no standardised practice or protocol for 
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the sampling and analytical determination of pharmaceuticals in water or any other 
environmental media that ensures the comparability and quality of the data generated. 
1.4 The Fate in the Environment receiving Pharmaceutical Active 
Compounds 
 
Before the late 1990s any environmental impact caused from the pharmaceutical industry was 
considered to arise solely from the manufacturing facilities i.e. from well-controlled emissions.  
It was appreciated that the pharmaceutical products themselves were biologically active, as 
Richardson and Bowron in the mid-1980s predicted the presence of pharmaceutical residues in 
surface waters [63].  However, it was not until 1994 where clofibric acid was identified in 
German rivers by Stan and his colleagues [64].  
None the less, the occurrence of PACs in the environment has become a worldwide issue of 
increasing concern.  As PACs are increasingly used in large amounts in human and veterinary 
medicine around the world, many of them may end up in the aquatic environment.  These 
findings have raised questions about how this mixture of human and veterinary medicines in 
the aquatic environment impact organisms in the environment and on human health [65].  
1.4.1 Adverse Effects on Organisms in the Environmen t  
 
The US Food and Drug administration (FDA) do not allow products on the market until 
environmental risk assessments has been performed.  These environmental risk assessments 
investigate the potential effects pharmaceuticals have on aquatic and terrestrial organisms. 
Risk assessments include the studies of potential negative effects on fish, daphnids, algae, 
bacteria, earthworms, plants and dung invertebrates.  The majority of the data collected is 
publically accessible.  However, the effects observed in these risk assessment tests are from 
concentrations much higher than those that are in measured in the environment.  They tend to 
use standard eco-toxicity tests that tend to focus on mortality as the end point.  For the 
aquatic tests, the risk assessments only measure the water compartment and do not consider 
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the potential pharmaceutical residing in sediments.  Therefore, less is known about the subtle 
effects that PACs can have on organisms in the environment, for example, growth, fertility or 
behaviour.  
With PACs being continuously being released into the environment, aquatic and terrestrial 
organisms are exposed for much longer durations than those used in the FDAs standard tests.  
Therefore, researchers are looking into some of the subtler effects caused by long-term, low-
level exposure from PACs.   A wide range of impacts reported so far are listed in table 1.1.  The 
case study below is a well-known example of PACs having adverse effects on wildlife [66]. 
 
Table 1.1 - A table reporting a few examples of pharmaceuticals found in the environment and their 
impact on the environment [66] 
 
 
 
 
 
Substance Drug Class Reported Effect 
Fenfluramine Anorectic 
It enhances the release of serotonin (5-HT) in  
crayfish which triggers the release of an  
ovary-stimulating hormone.  This results in larger  
oocytes with enhanced amounts of vitellin. 
Carbamazepine Analgesic 
It inhibits the activity of basal EROD in cultures  
of rainbow trout hepatocytes.  
Ibuprofen Anti-Inflammatory  
It stimulates the growth of cyanobacteria and  
inhibits the growth of aquatic plants. 
17a-Ethinylestradiol  Steroid 
It has endocrine-disrupting effects on fish,  
reptiles and invertebrates. 
Tylosin Antibacterial Impacts the structure of soil microbial communities 
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1.4.2 Feminisation of Fish  
 
Male wild fish in rivers and estuaries have been found with elevated concentrations of 
vitellogenin in their blood plasma or with a condition known as intersex, (intersex is a 
condition in which the reproductive ducts are feminised).  Intersex fish were first found by 
accident in 1976 [67].  Since then, comprehensive field surveys have shown that intersex fish 
are widespread in British rivers [68].  They have also been reported from many other countries 
[69].     These feminised fish were associated with exposure to sewage effluents suggesting 
that estrogenic chemicals such as estrogens used in the birth control pill, ethinyl estradiol 
(EE2), are the cause.  The discharge of estrogen into fresh water has caused male fish to 
produce viteollogenin, which is an egg-yolk that is produced in the liver of mature female fish.  
The implications of abnormal induction of vitellogenin in fish are not well known but high 
concentrations can lead to kidney failure [70]. 
Research conducted on various aquatic species, in particularly fish, where they were exposed 
under controlled conditions (known concentrations of EE2) showed that some aquatic 
organisms are exquisitely sensitive to EE2.  Studies have also predicted the maximum 
concentration limit of estrogenic chemicals having no effect on fish to be less than 1 ng/L.  
Concentrations at 1 ng/L can cause some degree of feminisation, however, results have shown 
concentrations as low as 4 ng/L to cause severe feminisation [71,72,73]. 
The consequence of the feminisation of wild fish population is presently unclear.  This is 
because it is not necessary for all male fish in a population to be able to breed successfully for 
the population to be sustained long term.  Therefore, the effect on population levels may be 
small or even non-existent even if the concentrations of estrogenic chemicals in the aquatic 
environment are high enough to adversely affect a proportion of fish.  However, this does not 
mean the population will not be compromised and the example of EE2 undoubtfully highlights 
the issue of PACs in the environment. 
27 | P a g e  
 
1.5 Removal of Pharmaceutical Waste from Water  
 
Currently there is a growing awareness of PACs being found in different water mediums 
leading to adverse effects on the environment and human health.  For that reason, it is 
important pharmaceuticals can be removed from waste water effectively and efficiently, in 
order to produce safe drinking water and to protect the environment.  Due to rapid population 
growth, water treatment facilities deserve more investment, particularly into the treatment of 
wastewater.  If waste water was treated appropriately it could be used as a large water 
resource to supply the needs of a growing economy.  The greatest challenge in implementing 
this strategy is the adoption of low cost wastewater treatment technologies that will maximise 
the efficiency of utilising limited water resources and ensuring compliance with all health and 
safety standards regarding reuse of treated wastewater effluents. 
A number of methods such as coagulation, filtration with coagulation, precipitation, ozonation, 
adsorption, ion-exchange, reverse osmosis and advanced oxidation processes (AOPs) have 
been used for the removal of organic pollutants from polluted water and waste water [74,75].  
These methods have been found to be limited, since they often involve high investment and 
maintenance cost.  Furthermore, AOPs have been found to effectively remove PACs but these 
processes can also lead to the formation of oxidation intermediates that are mostly unknown 
at this point.  Whereas, physicochemical treatments, such as coagulation processes, are 
generally found to be unable to remove PACs.  The main PACs which are known to pass 
through the treatment and remain in the wastewater include; analgesics, antibiotics, mood 
stabilisers, endocrine disruptors, contraceptives, stimulants, tranquilisers and statins [65,67]. 
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1.5.1 Waste Water from the Pharmaceutical Industry  
A wide range of water treatment and disposal methods are used in the pharmaceutical 
industry.  It is very difficult to apply a standard water treatment system because wastewaters 
generated from the pharmaceutical industry vary not only in composition but also in quantity, 
depending on the raw materials and the processes used in the manufacturing of various 
pharmaceuticals.  Also, the plant location brings in a variable relating to the quality of available 
water.  
One of the most common technologies applied is the advanced oxidising process which is 
mainly to remove organic compounds which are sometimes non-biodegradable.  Then the 
waste having enhanced biodegradability thus can be treated effectively by either an aerobic or 
anaerobic biological treatment method.  However, there are many alternative treatment 
processes are available to deal with the diverse range of waste produced from this industry, 
but they are specific to the waste the plant produces.  Some of the methods that are used to 
remove PACs from wastewater are discussed below.  
1.5.2 Recovery Processes   
Recovery processes include the following techniques; reverse osmosis, nanofiltration and 
ultrafiltration.  The pharmaceutical industry sees them as very important waste control 
techniques as they are able to recover PACs, along with other useful by-products, such as 
solvents, heavy metals and acid. 
Amoxicillin is an antibiotic used to prevent and treat many different types of bacterial 
infections.  Its recovery from the environment is very important due to it being widely used in 
human and veterinary medicine.  Nanofiltration (NF) can be used to separate and recover 
amoxicillin from pharmaceutical wastewater in order to palliate the antibiotics harm to the 
environment.  NF is a recently developed pressure driven membrane separation process, 
which has had an increasing number of applications within the last decade [76,77].  
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1.5.3 Activated Carbon  
Organic compounds are easily adsorbed by activated carbon (AC) due to its high surface area 
(over 1000m2/g) along with the combination of a well-developed pore structure and its surface 
chemistry properties.  A waste derivate of activated carbon has recently been used by Mestre 
et al. [78] to remove ibuprofen from water.  This is an advantageous process as the AC is an 
abundant raw material.  There are two types of AC; powdered AC or granular AC.  Granular AC 
is usually recycled in fixed bed columns, whereas, powdered AC is usually fresh, thus being a 
more efficient process [79,80].  Even with the high efficiency of powdered AC they are not cost 
effective and when granular AC becomes saturated, disposal/regeneration also becomes an 
issue [81].  However, the major problem with powdered AC is the separation of the adsorbent 
from the treated water; therefore, a filtration unit has to be integrated with it.  To overcome 
this problem, more recent studies are using AC along with other technologies, so that AC can 
be used as a pre-treatment [82].  Furthermore, it has also been published that AC adsorption 
may not always be successful in removing such organics [81].  
1.5.4 Advanced oxidation processes  
Most pharmaceuticals have a low biodegradability and the commonly employed treatment 
processes are not effective enough to completely remove these PACs from wastewater [83].  
Thus, the discharge of these compounds into receiving waters has proven to be high enough to 
cause toxic effects to environmental organisms [84,85].  AOPs have shown to be able to 
breakdown PACs.  AOPs can be broadly defined as aqueous-phase oxidation process based on 
the intermediate highly reactive species, such as hydroxyl radicals in the mechanisms, leading 
to the destruction of the target pollutant [86].  The main types of AOPs are heterogeneous and 
homogenous photocatalysis and this is dependent upon whether the treatment objective is 
transformation or destruction, together with the nature of the pharmaceutical effluent.  The 
AOPs can be employed alone or coupled with other physiochemical and biological processes.    
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1.5.4.1 Ozone/Hydrogen Peroxide Treatment 
Ozone is a very strong oxidising agent that decomposes in water to form hydroxyl radicals, 
which are even stronger oxidising agents.  The oxidising agents then induce an indirect 
oxidation or attacks certain functional groups of organic molecules through an electrophilic 
mechanism [86,87].  Pharmaceutical wastewater contains various organic compounds that 
exhibit resistance against biodegration, such as; tolune, phenols, nitrophenols and 
nitroaniline.   
In cases where treatment of pharmaceutical wastewater by AC adsorption is not financially 
feasible, ozone/hydrogen peroxide treatments appear to be better technologies.  Ozonation 
has largely been employed in removal of antibiotics [88,89].  However, compounds with amide 
linkages are resistant to ozone [90].  To overcome this problem, combination of ozone with 
hydrogen peroxide treatments can be employed, for example, the combination has been 
successfully utilised for degradation of penicillin formulation wastewater [89,91,92].   
1.5.4.2 Electrochemical Oxidation/Degradation 
The electrochemical method produces hydroxyl radicals (∙OH) as the main oxidant.  Hydroxyl 
radicals are the second strongest oxidising agent known after fluorine.  Hydroxyl radicals are 
able to non-selectively react with most organic contaminants via hydroxylation or dehydration 
until the chemical decomposes. This is due to the hydroxyl radical having such a high standard 
reduction potential (E◦(∙OH/H2O)=2.8 V vs SHE) [93].  The electrochemical method has shown 
complete degradation of pharmaceutical residues (simulated waste) such as; diclofenac, 
carbamezapine, propranolol, ibuprofen and ethinylestradiol.  Dominquez et al. [94] showed a 
satisfactory removal of total organic carbon (TOC) by the use of a boron doped diamond (BDD) 
anode which showed higher corrosion stability.   
It was also observed that by using BDD electrochemical treatment more than 97% TOC was 
removed from paracetamol and diclofenac spiked wastewater [95].  Whereas, the degradation 
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rate of the antibiotics was also enhanced with an increasing concentration of doping boron 
and decreasing electrode thickness.   
1.5.5 Conclusion  
 
From the literature reviewed above, it can be seen most of the technologies mentioned are 
“removal” processes.  However, there should be more of an emphasis on “recovery” 
technology research.  At the time of writing, researchers have been trying to implement 
recovery options in order to recover important and valuable reagents, by-products and 
solvents which can be reused. 
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1.6 The Removal of PACs from Wastewater by Adsorption  
 
Adsorption by solid adsorbents has the potential to be one of the most efficient methods for 
the removal of PACs from wastewater.  Adsorption techniques have advantages over the 
techniques mentioned above because of its simple and low cost design.  The adsorption 
process has had great deal of attention from researchers, as it can be used for the treatment 
of industrial wastewater from organic and inorganic pollutants.  Natural adsorbents include 
charcoal, clays and zeolites, as they are relatively cheap, abundant in supply and can be 
modified to enhance their adsorption capabilities. The following section describes how the 
properties and characteristics of zeolites has allowed them to absorb PACs from water, with 
particular reference towards the zeolites beta and clinoptilolite. 
1.7 Introduction to Zeolites 
 
In 1756, natural zeolites were discovered by Alex Cronstedt a Swedish mineralogist.  Zeolites 
are hydrated, crystalline microporous aluminosilicates.  Alex Cronstedt found that when 
heating the mineral Stilbite large amounts of steam were released.  This discovery led to the 
name zeolite, as ‘Zeo’ is the Greek word for boil and ‘Lithos’ means stone.  However, zeolites 
useful properties such as adsorption and ion-exchange were not recognised until the 19th 
century.  Their unique structural characteristics, such as the size of the pore window, the 
accessible void space, the dimensionality of the channel system, and the numbers and sites of 
cations, etc, have found roles in a variety of applications.  Zeolites can be used in adsorption, 
catalysis, building industry, agriculture, soil remediation, and energy [96,97]. 
There are many zeolites that occur naturally as minerals; however, the majority have been 
made synthetically.  At present, there are 200 different zeolite frameworks identified and 
recognised by the International Zeolite Association (IZA) [98].  Clinoptilolite, mordenite, 
phillipsite, chabazite, stilbite, analcime and laumontite are very common naturally occurring 
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zeolites.  With clinoptilolite being the most abundant naturally occurring zeolite, it is the most 
widely used natural zeolite around the world. 
The term “zeolite” is given to microporous, crystalline solid structures composed of aluminium, 
silicon and oxygen.  The general chemical formula of zeolites is: 
Mx/n·[AlxSiyO2(x+y)]·pH2O  
where M is (Na, K, Li) and/or (Ca, Mg, Ba, Sr), n is cation charge; y/x = 1–6, p/x = 1–4 [99]. 
Their structure is based on ‘vertex sharing’ TO4 (T=Si or Al) tetrahedral units that form a three-
dimensional four- connected framework with uniformly sized pores of molecular dimensions.  
These [SiO4] and [AlO4] tetrahedral units are the basic structural building units of a zeolite 
framework.   
 
 
 
 
 
 
 
 
 
Figure 1.2 - Diagram to show how in a zeolite each “T” atom (in blue) is co-ordinated to four atoms.  
Then each oxygen atom (in red) is bonding to two “T” atoms.  
6 -ring 
4 -ring 
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The distribution and arrangement of Si and Al atoms in the zeolite framework is difficult to 
determine.  This is due to their similar ionic radii and electronic shell arrangement of ions.   
However, it is known that the linkage of two tetrahedral Al atoms is forbidden, this is known as 
the Löwenstein’s rule.  Löwenstein’s rule dictates the ordering of [SiO4] and [AlO4] tetrahedra 
units in the framework, stating their distribution within a zeolite is not random.  This means 
that one Al atom can only connect with four adjacent Si atoms (denoted as Al[4Si]), whereas, a 
Si atom can link with either a Si atom or an Al atom.  Moreover, the Si:Al ratio of a zeolite can 
vary from 1 to ∞.  Changing the Si:Al ratio will alter the magnitude of the negative charge on 
the framework and will change the number of charge balancing cations needed, causing very 
little change to the structure.  
The silicon-oxygen tetrahedral unit are electrically neutral, however, the substitution of Si(IV) 
with Al(III) creates a charge imbalanced framework, with a net negative charge.  Therefore, 
each [AlO4]
5- requires a charge balancing cation to ensure an overall neutral charge.  These 
cations are located in the channels and cages of the zeolites structure, the number and 
location sites of these cations are of keen interest.  This is due to their effects on the 
performance of zeolites, such as ion-exchange and their catalytic properties.  However, there is 
still some limitation on the identification of the sites of cations, even with modern 
crystallographic techniques being applied to diffraction data [100]. 
1.7.1 Zeolites as Ion-Exchangers  
 
The most significant characteristic of a zeolite is that they are capable of exchanging ions with 
external medium.  The exchange of ions depends on several factors, including the framework 
structure, charge density of the anionic framework, the ion size and shape, as well as, the ionic 
charge and concentration of the external electrolyte solution [96].  Ion-exchange is 
stoichiometric and essentially a diffusion process, this means that the chemical kinetics usually 
has little relation to the process as a whole.   
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The equilibrium ion-exchange is expressed by the following equation:  
zBAZA
+ 
+zABLzB ⇔zAB
zB
+ 
+zBALzA  
Equation 1.1 – showing an equation expressing ion-exchange at equilibrium 
 
where L is defined as a portion of zeolite framework unit with an overall negative charge and 
the zA
+ and zB
+ are the valences of the respective cations.  
It was not until the early 1900’s that ion exchange was first commercially exploited as a water 
softening technique.  It was observed that the Na+ form of zeolite-A could produce soft water 
by ion-exchanging with Ca2+ and Mg2+ ions that are responsible for hard water.  Like most ion-
exchange reactions this process is completely reversible.  Zeolite-A can be regenerated once all 
the Na+ ions have been exchanged by simply passing a brine solution through the bed of 
inactivated zeolite [101].   
1.7.2 Zeolites as Molecular Sieves  
The water molecules in the pores and channels of zeolites can be removed by dehydration to 
leave a porous crystalline structure.  The dehydration has little to no effect on the anionic 
framework and results in large empty pores or “cages” that have a high affinity to re-adsorb 
water or other polar molecules.  Therefore, zeolites can be used as a drying agent, as 
dehydration is a reversible process.  However, it should be noted that the removal of water 
from zeolites can be more difficult for some zeolites than others.  This is due to there being a 
positive correlation between framework density and energy required for water diffusion.   
Molecular sieves are capable of adsorbing a considerable amount of water or other fluids.  As 
they are aided by the enormous internal surface area and by strong ionic forces, such as 
electrostatic fields, due to the presence of Na+, Ca2+ and K+ cations.  That being said molecular 
sieves can remove many gas or liquid impurities to very low levels (ppm or less).  Especially if 
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the species being adsorbed is a polar compound, it can be adsorbed with high loading, even at 
very low concentrations of the fluid, due to presence of cations in the zeolites framework.  
Another important feature of molecular sieve is their ability to separate liquids or gases by 
molecular size or polarity.  For example, a molecular sieve would be able to separate straight 
chained hydrocarbon paraffins from branched chains, as the normal, straight chained, 
molecules are able to fit into the pores and the branched molecules cannot enter the pores 
and would pass through molecular sieve bed un-adsorbed [102].  The pore or “cage” size is 
dependent on the number of oxygen molecules in the rings with 8-, 10- and 12- membered 
rings having typical sizes of ~4.5 Å, ~6.3Å and ~8.0Å respectively [103].  A useful way of 
tailoring the pore size is by ion-exchange.  The charge balancing cations are partially blocking 
the pores and reducing the pores overall size, thus, exchanging ions would cause a change in 
the amount of space within a unit cell.  This is an important feature as it is possible to 
synthesise zeolites with specific pore sizes, to allow adsorption of different molecule sizes, 
such as the example described above.    
Another way to alter pore size is by changing the zeolites Si:Al ratio.  The increase in the 
quantity of Si will decrease the size of the unit cell as the differences between bond lengths 
between Si-O and Al-O are around 1.61Å and 1.75Å.  This difference in bong lengths will, 
therefore, alter the overall size of the zeolites cavities.  Moreover, zeolites with higher 
quantities of Si will require a reduced amount of cations to balance the overall charge, this 
means the pore sizes are also less restricted by cations [104].  
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1.7.3 Other Applications and Uses of Zeolites  
Zeolites are frequently used as heterogeneous catalysts in for chemical reactions in industry.  
Zeolites make very good catalysts as they can be fully recovered and recycled with great ease 
and incur a relatively low cost.  This leads to less waste and fewer by-products, meaning that 
zeolites can be considered a greener alternative to common catalysts.  Their cation exchanging 
properties also allow zeolites to have different catalytic properties by using different cations.  
Also zeolites can often function with higher activity or may combine several catalytic steps 
which may reduce the environmental impact [105].  Examples of zeolites being used a catalysts 
include; isomerisation [106], cracking [107,108,109] and hydrocarbon synthesis [110,111]. 
Zeolites also have been researched by the pharmaceutical industry as drug carriers, adjuvants 
in anticancer therapy, dietetic supplements and antimicrobial agents.  The natural zeolite 
clinoptilolite has been used for all of above applications [112].  Clinoptilolite is non-
carcinogenic to humans and studies show it is not significantly toxic in animals [113].  Because 
of this and its high resistance in acid media, clinoptilolite is the main constituent in a large 
number of currently marketed dietary supplements and is in some antacid formulations [114] .   
There has been a lot of research into drug delivery systems with zeolites being the carriers.  
The reason being is that zeolites have very attractive features, such as: large surface areas, 
high pore volumes, abundant inner/outer surface chemistries, along with their good 
biocompatibility, thermal/chemical stability and resistance to corrosion under physiological 
conditions.  Their easily modified pore size and volume, along with ease of synthesis, also 
means they can be customised to their desired purpose.  Owing to these characteristics they 
have found wide application in adsorption, enzyme immobilization and drug delivery systems.  
In 2001, it was reported that MCM-41, a mesoporous material, was used to deliver ibuprofen 
[115].  
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1.7.4 Clinoptilolite 
Clinoptilolite [Figure 1.3] is the most abundant natural zeolite [116] with the following 
chemical formula:  
 (Na,K,Ca)2-3Al3(Al,Si)2Si13O36·12H2O  
 
It is reported to have a monoclinic crystal structure with the space group of C2/m.  
Clinoptilolite has a tetrahedral framework labelled HEU and it forms a continuous composition 
series known to the group of zeolites called the heulandite group.  This framework consists of 
three sets of intersecting channels all located in the (010) plane.  There are two channels 
parallel to the c-axis, with the A channels consisting of strongly, compressed, ten-membered 
rings with an aperture of 3.0 x 7.6 Å and the B channels consisting of eight-membered rings 
with an aperture of 3.3 x 4.6 Å.  The C channels consisting of eight membered rings with an 
aperture of 2.6 x 4.7 Å are parallel to the a-axis.   
The two main sites containing the charge balancing cations are the A and B channels.  The 
channels commonly contain the following ions; Na+, Ca2+, K+ and Mg2+.  Channel A contains Na+ 
along with Ca2+, whereas, B channel containing Ca2+ is mostly Na+ free.  K+ is found more 
centered in the C channel and in other nearby sites along with Na+.  The water molecules are 
found in the A and B channels.  The water molecules in the B channel are coordinated to Ca2+ 
and are commonly fully occupied unlike the water molecules in the A channels where they are 
generally only partially occupied [117].   
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Figure 1.3 - The structure of the natural occurring zeolite clinoptilolite
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1.7.5 Applications of Clinoptilolite 
Clinoptilolite is a well-researched zeolite because of its porous bulk structure and its ability to 
have broad range of surfactants on its surface.   It has been used as an absorber or as an ion 
exchanger in numerous studies to remove pollutants, deliver drugs, and be a dietetic 
supplement [118]. 
1.7.5.1 Surfactant Modified Clinoptilolite  
Clinoptilolites surface can be altered through treatment using cationic surfactants.  The charge 
balancing cations on the surface of clinoptilolite can be replaced to convert the external 
surface from hydrophilic to hydrophobic, or change the external charge from negative to 
positive by covering the surface with a surfactant bilayer [119].  For these reasons, the use of 
surfactant modified zeolites is a very common in removal of various pollutants [120].  For 
example, high-molecular-weight quaternary amines, such as hexa-decyl-tri-methyl-ammonium 
(HDTMA) replaced the charge balanced cations on the surface of clinoptilolite forming a 
bilayer.  The HDTMA enhances clinoptilolites sorption of Cs+ from nuclear waste [121].      
1.7.5.2 Removal of Pollutants by Ion-exchange and adsorption 
An excess of nitrogen in the environment causes eutrophication of lakes and rivers.  
Ammoniacal nitrogen (NH2-NH2) is a colourless, toxic gas, often found in industrial waste water 
and cause a sharp decrease of dissolved oxygen.  The decrease in dissolved oxygen can cause 
eutrophication of lakes and rivers, hence, it is of great importance to remove ammonia from 
natural waters.  The removal of the ammonium ions from aqueous solutions through 
adsorption using clinoptilolite is found to be very promising.  The Tahoe-Truckee Sanitation 
Agency, California, extracted 507kg of NH4
+ from waste water a day by using clinoptilolite for 
ammonia exchange.  Whereas, NASA used Ca-saturated clinoptilolote to remove ammonia 
from a wastewater system to establish long term human presence in space.  
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1.7.6 Zeolite Beta 
Zeolite Beta is a mixture of related polymorphs [Figure 1.4] which was first reported in 1967, 
they are highly siliceous, large-porous, synthetic zeolites obtained by using tetra-ethyl-
ammonium hydroxide as structure-directing agent. Their high thermal and chemical stability, 
together with the presence of strong acid sites on the surface has made zeolite beta an active 
and efficient catalysts for a wide spectrum of reactions in industry [122]. 
 
Figure 1.4 - Framework structures of (a) polymorph A, (b) polymorph B, and (c) polymorph C of zeolite 
beta, showing the different stackings of the 12-ring pores as (a) ABAB. . ., (b) ABCABC. . ., and (c) AA. . .. 
[123]
 
 
Their framework consists of three polymorphs; A, B and C [Figure 1.4].  Polymorph A (*BEA, 
P4122, a=12.632 Å and c=26.186 Å), polymorph B (C2/c, a=17.896 Å, b=17.920 Å, c=14.328 Å, 
and β=114.8 °), and polymorph C (BEC, P42/mmc, a=12.769 Å and c=12.977 Å).  Whilst the 
structure of polymorph C was determined using several different techniques, the structures of 
polymorphs A and B are still hypothetical [123].  The polymorphs have three-dimensional pore 
systems with 12-rings as the minimum constricting apertures, however, they are all built from 
the same tertiary buildings units just in different sequences.  They can either be 
interconnected in a left (L) or right (R) hand fashion.  Polymorph B has a uninterrupted 
sequence of (RRRR…) or (LLLL..), whereas, polymorph A has an alternative stacking sequence 
(RLRLR….).  There is equal probability of either stacking sequences occurring, as a result of this, 
there is a random extent of interplanar stacking faults and to a lesser extent, intraplanar 
defects terminated by hydroxyl groups.  The intergrowth of the polymorphs does not 
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significantly affect the volume of the pores but influences the tortuosity of the pore 
connectivity along the c direction.  The high stacking fault densities produces complex X-ray 
diffraction patterns that have both sharp and broad features [124].  
1.8 Porous Silicates as Pharmaceutical Adsorbents 
 
The removal of contaminants by adsorption using natural materials such as zeolites has, has 
gained much interest during recent decades. H.M. Otker et. al [125], used clinoptilolite, a 
natural zeolite, to remove the veterinary antibiotic enrofloxacin.  Enrofloxacin is a 
fluoroquinolone group antibiotic, which is widely used in poultry production in order to treat 
respiratory and enteric bacterial infections.  Their results showed that the optimum uptake of 
enrofloxacin by clinoptilolite was obtained by decreasing pH and increasing temperature.   
Clinoptilolite was used again in another study [126] in attempt to remove dexamethasone.  
Dexamethasone is a type of glucocorticoids, that cannot be removed efficiently from hospital 
wastewater using conventional on-site treatment methods. Dexamethasone can cause many 
adverse effects when it is contaminating the aquatic environment.  Organisms exposed to this 
drug can be expected to have a weakened immune system and as a result of this, can be at 
high risk of suffering from an infectious disease.  Their study showed that the removal 
efficiency was dependent on the solutions pH, initial concentration of dexamethasone, amount 
of adsorbent and contact time.  Maximum removal of dexamethasone occurred at pH 4 along 
with 0.5g of Clinoptilolite.     
An investigation into zeolite beta, with different Si:Al ratios (i.e. 25, 38 and 360), adsorbing the 
three pharmaceuticals; atenolol, hydrochlorothiazide and ketoprofen, from diluted aqueous 
solutions, was performed in 2013 [122]. The researchers investigated the effect of changing 
the ionic strength and the pH, before and after thermal treatment of the adsorbents.  Analysis 
by X-ray diffraction and thermogravimetry confirmed the drug adsorption. The results showed 
that the adsorption capacity of beta zeolites was strongly dependent on both the solution pH 
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and the alumina content of the adsorbent.    Atenolol was readily adsorbed on the less 
hydrophobic zeolite, under pH conditions in which electrostatic interactions were 
predominant.  Whereas, the adsorption of ketoprofen was mainly driven by hydrophobic 
interactions. In addition, it was shown that thermal treatment, presence of cations or buffered 
solutions can significantly modify the adsorption characteristics of zeolite beta.  Their results 
showed that by adding salt to the solution it was found that drug desorption was more 
favourable. This would be helpful once the zeolites had been removed from the treated water 
as it would allow for the drugs to be removed and the zeolites to be used multiple times. 
MCM-41 and SBA-15 are both mesoporous silica sieves that are composed of uniform ordered 
structures, along with high pore volume and high surface area.  They have both been 
investigated as adsorbents for the removal of pharmaceuticals from aqueous solution. In 2008 
[127], MCM-41 was incorporated with nickel (II) complexes in attempt to remove naproxen.  
Their results indicated that the inclusion of the transition metal nickel onto the surface of 
MCM-41 improves the materials affinity towards naproxen in aqueous mediums.   
Whereas, a different study in 2009 [128], used the mesoporous silica SBA-15 to adsorb the 
following pharmaceuticals; carbamazepine, clofibric acid, diclofenac, ibuprofen, and 
ketoprofen from aqueous solution.  X-ray diffraction, transmission electron microscopy, N2 
adsorption-desorption measurement, and point of zero charge measurement, were used to 
synthesise and characterise the adsorbent SBA-15.   
Their results showed that SBA-15 is a promising adsorbent for removal of pharmaceuticals 
from surface water and from pharmaceutical industrial wastewater.  The highest removal rates 
achieved were in acidic media (pH 3-5), reaching 94.3% uptake of ketoprofen, closely followed 
by ibuprofen with 93.0%, diclofenace with 88.3%, carbamazepine with 85.2% and clofibric with 
the lowest of 49.0%.  It was found that by increasing pH above 5 caused a decrease in the drug 
uptake.  On the other hand, the researchers also confirmed that SBA-15 had low desorption 
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percentages, implying that the adsorbed pharmaceutical would not easily detach from the 
adsorbent to return to the treated water.  
In 2012, a research study attempted to remove the three drugs; erythromycin (ERY), 
carbamazepine (CBZ) and levofloxacin (FLX) from water using three organo-philic zeolites; Y, 
mordenite (MOR), ZSM-5 [129].  Their results indicated that Zeolite Y [Figure 1.5] was the most 
efficient adsorbent, with the material being able to adsorb ERY and FLX at up 5% and CBZ as 
much as 10% of its as-synthesised weight.   X-ray diffraction patterns were analysed by the 
Rietveld method to determine the unit parameter variations and structural deformations of 
the zeolites after adsorption.  The results showed that after adsorption of the tested 
antibiotics, that zeolite Y showed remarkable distortion in its framework, which caused a 
lowering in the symmetry of FLX and CBZ.  Therefore, they concluded the drugs were adsorbed 
inside the channel system of zeolite Y.  It was also noted that ERY is adsorbed inside the 
crystals of zeolite Y even if its dimensions appeared to be too large to pass through the 12-ring 
windows delimiting the large cage of this zeolite.  Furthermore, the results also showed that 
CBZ is not adsorbed by either MOR or ZSM-5, even if the dimensions of the drug appear 
suitable for adsorption in the channel system of these microporous materials.     
 
Figure 1.5 – Image of zeolite Y 
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1.9 Drug Molecules Used In This Research  
 
Both ibuprofen and paracetamol are two of the most commonly detected PACs in waste water 
across the world.  Ibuprofen was detected in 56 countries with a concentration range of 0.034 
μL-1 to 0.0506 μL-1, whereas, paracetamol was detected in 29 countries with an average 
concentration of 0.038 μL-1. 
1.9.1 Ibuprofen  
Ibuprofen is a common nonsteroidal anti-inflammatory drug (NSAID), treat minor pain, fever 
and inflammation [130].  In 2015, Nurofen (ibuprofen based pharmaceuticals) sold 
approximately £117.5 million of the drug [131].  Its chemical structure is shown in figure 1.6: 
 
 
 
 
 
 
Figure 1.6 - Chemical structure of Na-Ibuprofen, Na is represented by the purple atom, O is represented 
by the red atoms and C is represented by the grey atoms. 
Ibuprofen metabolises in an organism’s digestive system.  Its metabolites include 
hydroxyibuprofen and carboxyibuprofen.  It is important to understand that these two 
chemicals retain the same low level of toxicity as the parent compound [132].  One of the main 
routes for ibuprofen to enter the aquatic environment is excretion, with 90% of ingested 
ibuprofen being excreted by urine [133].  It is no surprise that 0.22 μgL-1 of ibuprofen was 
identified in German sewage effluents [134].  In 2002, a research group tested 139 streams 
across the U.S for PACs.  9.5% of the streams tested had traces of ibuprofen (0.018-1. μgL-1) 
[135].  A different research group tested the same 139 streams 5 years later and found that 
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the concentrations of ibuprofen in the streams had increased to 0.90-2.11 μgL-1 [136].  This has 
raised questions to whether ibuprofen is persisting in the environment and what effects it has 
on organisms in the aquatic ecosystem. 
Several studies have looked into how concentrations of ibuprofen may affect aquatic life.  One 
particular research group studied the growth effects of two aquatic species; Synechocystis and 
Lemna minor, using 1-100 μgL-1 ibuprofen [137].  The strain of Synechocystis used was 
Synechocystis sp. PCC6803, which is a freshwater cyanobacteria.  Lemna minor is a common 
duckweed which is also a found in fresh water.    Their results showed that ibuprofen strongly 
stimulated the growth of Synechocystis at all concentrations tested, with a 72% increase at 10 
μgL-1.  However, ibuprofen inhibited Lemna minor in a linear dose-dependent manner with a 
25% growth reduction with an ibuprofen dosage of 1μgL-1.  The effects shown by ibuprofen on 
Synechocystis and Lemna minor growth may have potential implications to the ecosystem.  As 
the loss of one organism in a small ecosystem could mean disaster for the other organisms in 
the same ecosystem.   In the case of ibuprofen harming humans there is a growing concern 
with prolonged use of ibuprofen. Many health specialists are concerned that ibuprofen can 
cause gastrointestinal, cardiovascular, kidney and brain conditions [138].   
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1.9.2 Acetaminophen  
 
Acetaminophen, also known as paracetamol, is one of the most prescribed drugs globally due 
to its antipyretic and analgesic properties [139,140,141,142].  Its chemical structure is shown 
in figure.  The minimum concentration for a therapeutic effect on invertebrates is 9.2μL-1. 
[143].  However, it is highly toxic at elevated doses and can cause hepatotoxic, a condition that 
can occur in both animals and humans [142,144,145,146].  
 
 
 
 
  
Figure 1.7- Chemical structure of Acetaminophen, oxygen is represented by the red atoms, nitrogen is 
represented by the purple atom and carbon is represented by the grey atoms  
 
Paracetamol administrated in normal dosages results in non-toxic metabolites that are 
promptly excreted. A higher dosage of paracetamol along with the unavailability of 
intracellular glutathione can result in toxic effects.  Without glutathione the highly reactive, 
electrophilic metabolite of paracetamol (N-acetyl-p-benzoquinoemine, NAOQI) will 
accumulate and cause toxic effects such as; DNA and RNA damage, oxidation of membrane 
lipids, modification of thiol groups on cellular proteins, resulting in necrosis and cellular death.  
Therefore, a saturated detoxification mechanism or a lack of a similar detoxification 
mechanism in non-target organisms are likely to exhibit the toxic effects 
[142,145,146,147,148]. 
The environment concern surrounding paracetamol stems from its common presence in the 
aquatic environment.   Paracetamol degrades naturally in the environment by 57-99% within 
28 days [149], however, it is the continuous discharge and the time taken to degrade that 
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causes paracetamol to persist in the environment.  The persistence of paracetamol is well 
documented, with concentrations of up to 6 μL-1 in European sewage plants [150], 10 μL-1 in 
USA natural waters [151] and above 65 μL-1 in the River Tyne, UK [152].  Despite this, the 
number of ecotoxicological studies on potential effects of paracetamol in wild organisms is still 
scarce. 
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1.10 Introduction to Drug Adsorption 
 
Adsorption is “the preferential partitioning of substances from the gaseous or liquid phase 
onto the surface of a solid substrate”.  The material being adsorbed onto the solid is known as 
the adsorbate and the solid which the adsorbate accumulates onto is called the 
adsorbent.  This process is reversible as the physical adsorption is caused mainly weak van der 
Waals and electrostatic forces.   
For a solid to provide large adsorption capacity it must have a large specific surface area, this 
can be created by having a large number of small sized pores between adsorption 
surfaces.  The size of these pores determines the accessibility of the adsorbate to the 
absorbents internal surface.  Therefore, the absorbents can be ‘tuned’ for a particular 
separation process by being engineered to have specific pore sizes distribution [153].    
Zeolites are hydrophilic adsorbents which have a high affinity towards polar substances such as 
water.  With most PACs being polar it was for this reason zeolites have been explored for being 
a potential absorbent.   
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1.11 Research Proposal 
Pharmaceuticals have only recently been considered as CECs and as a result of this, have 
received a lot of attention from scientists.  Pharmaceuticals have been detected in the 
aqueous environment with concentrations up to the g/L and as high as 100g/L in effluents 
from pharmaceutical manufacturers.  Most pharmaceuticals are readily soluble in water due to 
their polar properties and consequently, they cannot be completely removed from 
wastewater.  This is due to current wastewater treatments systems being based on filtration 
and hence, not designed to remove polar pharmaceuticals from water.  Therefore, alternative 
treatment technologies that achieve efficient pharmaceutical removal need to be developed.  
Among the several technologies propose for the removal of pharmaceuticals from water, 
adsorption has been receiving special attention due to its simplicity, no production of 
undesirable by-products, low setup and operation cost [154].  
In the last decade, zeolites have attracted great attention as they are affordable materials that 
are abundant and inexpensive.   They have high surface area, large and uniform pore size, high 
pore volume and tailorable surfaces that make them good candidates for the adsorption 
removal of pharmaceuticals.  The aim of this study, was to determine the adsorption capacities 
of natural zeolite clinoptilolite and the synthetic zeolite beta towards the two pharmaceuticals 
that are recognized as emerging contaminants of water: acetaminophen and Na-ibuprofen.  
Apart from their frequent occurrence in wastewaters, these pharmaceuticals were chosen 
because of their molecular structures.  They both possess polar groups which can be expected 
to adsorbed on three-dimensional ordered solids that possess specific active sites [155]. 
Zeolite beta was chosen as an adsorbent as they are commercially ready, have a defective 
structure and large pores, which are ideal characteristics for the adsorption of drugs with 
moderate molecular dimensions.  Although zeolite beta show great potential as 
pharmaceutical adsorbents, there has been relatively a few studies performed on these 
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materials unlike clinoptilolite which has been investigated as a potential adsorbent in 
numerous studies. 
As the addition of specific cations can adjust and even tailor the adsorption affinities of the 
zeolites, both zeolites were ion-exchanged with: Cu(II), Fe(III) and NH4
+.  It is thought that the 
adsorption of acetaminophen and Na-ibuprofen, on the three-dimensionally order solids, that 
contain these specific cations, will occur as both pharmaceuticals possess polar groups.  
Acetaminophen contains one alcohol group and one amide group, and Na-ibuprofen contains a 
carboxylic group.  It is thought that N- and O- donor groups will form stable complexes with 
Cu(II) ions.  Whereas, the Fe(III) cations were introduced with the aim to strongly bind with the 
oxygen atoms present on the target drugs and the NH4
+ cation were exchanged with the aim to 
increase adsorption via hydrogen bonds.   
 To determine the adsorption properties of the zeolites, XRD, IR and HPLC will be used.  If the 
pharmaceuticals are adsorbed, the analytical techniques IR and XRD would contain peaks 
representing the drug uptake.  Whereas, HPLC would be used in attempt to quantify the 
percentage of drug adsorbed, in order to determine the best adsorbent.   
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Chapter 2: Experimental Techniques  
 
2.1 Powder X-Ray Diffraction (XRD) 
 
Zeolites and other related microporous materials are made up of a range of structures and 
compositions. Since the earliest of days X-ray diffraction has been one of the main and useful 
analytical technique for structural characterisation.  In 1912, Max von Laue discovered that the 
three dimensional array of atoms or molecules making up crystalline substances can act as a 
diffraction grating for X-ray wavelengths similar to the spacing of planes in a crystalline lattice 
[156].  X-ray diffraction is based on constructive interference of monochromatic X-rays with a 
crystalline sample.  The diffraction pattern produced can be used to determine a structural 
model of which either the Laue equations or Bragg’s law can be used.   
The Laue equations are based on the idea that the 3-dimensional network of atoms behaved 
as a 3-dimensional diffraction grating.  Despite Laue’s approach being correct it was often not 
used as it was seen as too complicated.  This led to advances in Bragg’s law which relates the 
wavelength of electromagnetic radiation to the diffraction angle and the lattice spacings in a 
crystalline sample [Equation 2.1]. The equation for Bragg’s law is the following: 
 
nλ=2dhkl sin θ    
Equation 2.1- Equation for Bragg’s law [157]
 
   
where λ is the wavelength, n is the order of reflection, dhkl is the perpendicular lattice plane 
distance and sin θ is the angle of incidence/reflection to the plane [157].  
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Figure 2.1 – Diagram of Bragg’s law [158]
  
When X-rays interact with crystalline solids they are scattered in all directions due to the 
random orientation of microcrystallites.  When the geometry of the incident X-rays impinging 
the sample satisfies Bragg’s law (when two incident waves remain in phase), constructive 
interference occurs and a peak in intensity occurs.  However, if the two waves are out of 
phase, this means no diffraction will occur as Bragg’s law is not satisfied.  Due to the random 
orientation of crystallites there will always be in phase waves which are satisfying Bragg’s 
equation leading to a diffraction pattern being produced [159].     
X-ray diffractometers consist of three main elements: X-ray tube, X-ray detector and a sample 
holder.  X-rays are generated in a cathode ray tube by heating a filament to produce electrons 
and fired at a metal anode, commonly copper.  X-rays are produced when the high energy 
electrons ionise coppers inner shell electrons to produce vacant orbitals.  When this occurs 
electrons from a higher energy level drop down and release excess energy in the form of X-
rays of a characteristic wavelength.  The spectra produced consists of several components, 
with the most common being Kα and Kβ.  Kα is made up of Kα1 and Kα2, with Kα1 having a 
slightly shorter wavelength and twice the intensity.  Monochromaters are filters and are 
required to produce the monochromatic X-rays needed for a diffraction pattern.  The 
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monochromators are often used within diffractometers to select only Kα1 as the two spin 
states of electrons will provide radiation at λ=1.54051 Å (Kα1) and λ=1.54433 Å (Kα2) [160]. 
The scattering of X-rays by the electrons within a sample produces a diffraction pattern.  The 
intensity of the patterns peaks can provide useful information such as the crystal structure and 
stacking faults of the sample.  The equation for the intensity (Ihkl) of a given peak within the 
diffraction pattern is as follows:  
Ihkl = K(Lp)hkl jhkl F
2
hkl e
-2w  Ahkl     
Equation 2.2 – The equation used to calculate the intensity of a given peak within a diffraction  
 
K is the scale factor normalizing experimentally observed intensitites with calculated 
intensities 
(Lp)hkl is the Lorentz-Polarisation factor, this contains two parts, the Lorentz factor and the 
polarization factor 
jhkl is the multiplicity of the [hkl] planes 
W is the debye temperature correction factor 
Ahkl is the absorption factor 
Fhkl is the structure factor [161]  
The structure factor (Fhkl
2) proportional to the intensity of a peak in a diffraction pattern.  With 
the structure factor being dependent on the type of atom and their location within a unit cell it 
can be assumed that the nature or location of atoms has changed if the relative intensity has 
changed.  Therefore, measuring the change in intensity is very important when analysing 
diffraction patterns from ion-exchanged samples.  Analysis of the intensity can help determine 
crystal structures as it can determine atomic positions, occupancy, temperature factors and 
texture. 
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XRD patterns can also be used as fingerprints for the identification of known minerals, 
however, other information is needed when dealing with unknown substances.  For instance, 
peak position in terms of 2θ values can determine the unit cell dimensions, symmetry along 
with space groups by determining the positions of reflections.  However, it is important to 
ensure consistency when preparing samples as high background readings can indicate 
scattering from the sample holder.  High background readings can also be from amorphous 
material within a sample [162]. 
XRD patterns can also provide information on the size of the crystallites by using the Scherrer 
equation [Equation 2.3].  Scherrer equation states that peak width is inversely proportional to 
particle size, thus, sharp peaks implies large crystallites and broad peaks indicates small 
crystallites [156].          
    𝑺𝒊𝒛𝒆 (Å) =  
𝒌𝛌 
∆𝜽 𝒙 𝒄𝒐𝒔𝜽
    
Equation 2.3 – Scherrer equation [156]
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2.1.1 XRD Experimental  
Diffraction patterns were obtained using a Bruker D2 phaser powder diffractometer fitted with 
0.6mm slits and a Lynxeye solid state detector fitted with 0.6 mm slits and a Lynxeye solid 
state detector fitted with a 1mm solar slits using CuK radiation (λ = 1.5418 Å) and a Ni Kβ filter, 
between 3-80° 2θ with a 30 minute scan. 
The X-ray diffraction patterns are analysed using the Pawley fit method.  The Pawley fit 
method is a process in which the peaks observed in a XRD pattern are fitted by 2-theta values 
constrained by the size and symmetry of the unit cell.  The structural refinement of the unit 
cell gives an indication of the “best fit possible”.  By extracting the peak intensities before 
structural solution the software can determine the cell parameters [163].  A Pawley fit can also 
determine any changes made to zeolites unit cell parameters due to adsorption.  For the X-ray 
diffraction patterns obtained the parameters were refined with a Pawley fit, using a Chebyshev 
background function and pseudo-Voight peak shape function.  If the unit cell results change 
significantly after adsorption (the change is larger than the calculated error), then it is an 
indication that the drug has adsorbed into the pores rather than attached to the particles on 
the surface.  
The Pawley fit method was also used to see if the unit cells of the samples fits well to the 
structural model.  This was done by evaluating the weight profile R-factor (Rwp) and also by 
visual examination of the fit for each XRD pattern collected.    The Rwp is the most 
straightforward discrepancy index, with the following equation:  
𝑹𝒘𝒑
𝟐 = ∑ 𝒘𝒊
𝒊
(𝒚𝑪,𝒊 − 𝒚𝑶,𝒊)
𝟐/ ∑ 𝒘𝒊(𝒚𝑶,𝒊)
𝟐
𝒊
 
 
Equation 2.4 – The weight profile R-factor (Rwp) equation 
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The equation follows direction from the square root of the quantity minimised, scaled by the 
weighted intensities [164].  It is regarded as the target of a correct structural refinement, thus 
the smaller the Rwp value the better [165]. 
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2.2 An Introduction to High Performance Liquid Chromatography (HPLC) 
 
Chromatography is a technique used to separate components in a mixture due to the differing 
time taken for each components carried in a mobile phase to travel through a stationary 
phase.  Chromatography was first used in 1906 by a Russian botanist, Mikhail Tswett.  He 
separated plant pigments such as chlorophylls and xanthophylls by passing them through a 
glass column packed with calcium carbonate [166].   
High Performance Liquid Chromatography (HPLC) is characterised by the use of mobile phase 
being pumped through very small particles (stationary phase) at high pressure.  It is the most 
common analytical separation tool that is used to identify, quantify or purify the components 
of a mixture.  For HPLC the stationary phase is typically a column filled with surface-modified 
silica particles.  The particles in the columns are extremely small with typical values of 5 
microns.  There are many different columns differing in particle sizes.  It is the high-surface 
area stationary phase that maximises the interaction between the substance to be separated 
and the stationary phase, resulting in a better separation [167].  
Analyte is the term used to refer to the molecule of interest that is being analysed.  The time at 
which an analyte emerges from the column is known as the retention time.  The retention time 
of each analyte depends on its chemical nature and the composition of the mobile phase.  This 
is because as the sample is pumped through the column it interacts with the stationary phase 
through a combination of hydrophobic and van der Waals interactions [168].  
 
 
 
59 | P a g e  
 
The separation of the analytes happens inside the column and a detector “collects” this 
separation allowing us to see it [Figure 2.2].  There is no universal detector, however, a UV/VIS 
detector is a very common type of detector used for HPLC analysis and was used in the 
experimental explained below.  A UV/VIS detector comes under the category of absorbance 
detectors.  During the analysis, the samples goes through a flow cell.  When UV light is 
irradiated on the flow cell, the analyte absorbs a part of the UV light.  Therefore, the intensity 
of the UV light absorbed by the mobile phase with analyte and without analyte will differ.  This 
difference in intensities determines the amount of analyte detected.  The wavelength used 
depends on the type of sample being detected.  The most commonly used wavelength is 
254nm [169]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 -The configuration of a typical HPLC system [166] 
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2.2.1 HPLC Experimental  
 
PU-1580 intelligence HPLC with a Waters 486 absorbance detector was used to analyse 
samples.  The HPLC parameters are stated in table 2.1.   
Table 2.1 -The HPLC parameters used for quantifying adsorption of acetaminophen and Na-
ibuprofen 
Analyte 
Run Time 
(minutes) 
Wavele
ngth λ 
(nm) 
Flow Rate 
(mL/min) Mobile Phase 
Acetaminophen 7.00 254 1.00 40 Methanol: 60 Water: 1.6 Acetic Acid 
Na-Ibuprofen 15.00 220 1.00 
45 Water: 55 Acetonitrile: 0.045 Phosphoric 
Acid 
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2.3 An Introduction to Infra-Red Spectroscopy  
Infra-red (IR) spectroscopy uses IR radiation which is a type of electromagnetic radiation.  
When an IR radiation wave interacts with a covalent bond which has an electrical dipole, the 
radiation energy is absorbed and the bond will start to vibrate.  This type of analysis is 
performed on an IR spectrophotometer.  Older spectrophotometers slowly scan through the 
whole IR spectrum, however, modern machines use the Fourier Transform (FT) method [170].  
This method uses an interferometer instead of a diffraction grating.  It analyses the sample 
using a single pulse from an IR laser and all frequencies reach the detector at the same time.  
The spectrum is obtained by a mathematical calculation and is then converted on a computer 
to a readable form.  The spectrum produced normally has a ‘plot’ of % transmittance against 
wavenumber. Wavenumber is expressed as [171]. 
Wavenumber (cm-1) =  
𝟏
𝐰𝐚𝐯𝐞𝐥𝐞𝐧𝐠𝐭𝐡 (𝐜𝐦)
 
Equation 2.5 – Equation for wavenumber 
No two organic compounds have the same IR spectrum, therefore, an individual, pure 
compound can be identified by examination of its spectra [171].  The energy at which any peak 
in an absorption spectrum appears corresponds to the frequency of a vibration of a part of a 
sample molecule:   
c = νλ            
Equation 2.6 – The equation for wavelength [171]
]
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where,              
c = velocity of light (3.00 x 108 m s-1) 
ν = frequency (Hz) 
λ = wavelength (m) 
and  
E = hν     
Equation 2.7 – Planks law equation   
where,                         
E = energy (kJ mol-1) 
h = Planck’s constant (6.63 x 10‑34 J/s) 
ν = frequency (Hz) [171] 
2.3.1 IR Experimental  
A Nicolet IR2000 FT-IR machine was used to determine whether the pharmaceuticals had been 
successfully adsorbed by the zeolites.  A background scan is run first to remove CO2 peaks and 
other artefacts found in the air.  A small sample is then placed onto a clean attenuated total 
reflection (ATR) cell sample plate to be scanned. 
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2.4 Introduction to Solid State Nuclear Magnetic Resonance (MAS NMR) 
 
Nuclear magnetic radiation (NMR) is an extremely valuable technique for determining 
molecular structure and providing structural information on solids.  NMR spectra for liquids 
give a number of sharp peaks, with their positions and intensities providing information on 
which atoms are bonded together, co-ordination numbers, next nearest neighbour etc.  
Whereas, NMR spectra, obtained from solids, provide broad featureless peaks.  The broad 
featureless absorptions are caused by chemical shift anisotropy and dipolar coupling, due to 
the absence of molecular motion.  Therefore, no useful information such as; chemical shifts 
and spin-spin coupling can be extracted from the broad line shapes [172].    
Magic angel spinning (MAS) removes the anisotropies of the chemical shift and dipole-dipole 
interactions producing a liquid-type NMR spectrum that structural information can be 
obtained from.  The solid sample is rapidly rotated at a frequency in the order of kHz and at 
the so-called ‘magic angle’ of 54.74° to the applied magnetic field.  The fast rotation averages 
the chemical shift and the dipole-dipole interactions to the values they would have if they 
were in a liquid solvent [173], resulting spectra are composted of sharp peaks producing much 
structural information.   
Lippma and others first applied MAS NMR to crystalline silicates and found that it determines 
the position of silicate anions when using 29-Si NMR.  The position of the peaks in the spectra 
can distinguish between isolated SiO4 tetrahedra and SiO4 tetrahedra linked by their corner 
oxygen atoms to 1, 2, 3 or 4 AlO4 tetrehedra.  A ‘Q’ value is assigned to represent the number 
of adjacent corner sharing SiO4 tetrahedra.  Q values range from zero to four.  An example of a 
solid with a Q value of zero is the orthosilicate Mg2SiO4.  
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The chemical shifts for a 29-Si NMR spectra depends approximately on the Q values [Figure 
2.3].  For each Q value, a range of chemical shifts are present which are relative to the internal 
standard tetramethylsilane (TMS) [172].   
 
Figure 2.3 - The positions of 
29
Si NMR peaks in silicates as a function [172] 
2.4.1 MAS NMR Experimental 
 
All 29-Si MAS NMR results were obtained on a Bruker AB3, 400MHz ultra-shield, with the 
parameter settings in table 2.2. 
Table 2.2 – Parameters used for all 29-Si MAS NMR 
Pulse Programme Zg 
Spin Speed 6 kHz 
Relaxation Delay 10 sec 
Lamor frequency 79.45 MHz 
Reference Standard TMS, 0ppm 
Number of 
Acquisitions 1024 
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2.5 An Introduction to Scanning Electron Microscopy 
 
A scanning electron microscope (SEM) is an analytical instrument commonly used to 
determine composition, morphology.  SEM is similar to the transmission electron microscope 
(TEM) in that they both fire a beam of electrons at the sample.  Therefore, the two 
microscopes share similar features such as; the electron gun, vacuum system and condenser 
lenses, however, SEM produces images differently to TEM.  SEM can typically magnify a 
material from 10-300,000 times.  By using the scale bar, which is shown on the SEM image, the 
size of the image can be calculated.  SEM, therefore, can provide information on the size and 
the morphology of the zeolite and can show if the PACs adsorbed affect or damage the 
morphology of the zeolite.  
The electrons are normally produced by a field emission gun that can produce high resolution 
images.  These electrons are accelerated to an energy which is typically between 1-30 keV, this 
is considerably lower than TEM which uses energies around 100-300keV.  The beam of 
electrons pass through two or three condenser lenses that de-magnify the electron beam 
before it hits the sample, this causes the beam to only have a diameter of 2-10nm.  The 
position of the electron beam on the sample is digitally controlled and the resultant imaged is 
displayed on a computer screen. Moreover, the signals are produced can be electronically 
cleaned and amplified before being displayed [174]. 
The electrons passing through the sample are separated into various types as they emerge; 
being collected according to angle of scatter, or energy loss or both [175].  It is the diffracted 
electrons (elastic scattering) leaving the sample that produce the image.  Elastic scattering is 
where the electron beam loses energy from electrons interactions with the sample surface 
atoms.  The energy loss is caused by the sample surface atoms releasing secondary electrons.  
The release of secondary electrons is useful for imaging as there is a positive correlation 
between number of secondary electrons and brightness [174].   
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2.6 An Introduction to Energy Dispersive X-ray Spectroscopy  
 
Energy dispersive X-ray spectroscopy (EDX) is used in conjunction with SEM as a chemical 
microanalysis technique. EDX can analyse samples as small as 1m.  The sample emits X-rays 
when it is bombarded with electrons from the SEM’s electron beam.  The samples surface 
atoms eject electrons when it is hit by the electron beam.    This results in empty electron 
vacancies to be filled by electrons from a higher state causing an X-ray to be emitted to 
balance the energy difference between the two electrons states.  It is these X-rays which are 
detected by the EDX and are used to characterise the elemental composition of the sample, as 
the X-ray energy is characteristic of the element from which it was emitted from. 
The EDX X-ray detector is typically a lithium-drifted silicon solid-state device that measures the 
relative abundance of emitted X-rays versus their energy.  The detector creates a charge pulse 
that is proportional the energy of the X-ray that it receives.  A charge-sensitive preamplifier is 
then used to convert charge pulses to voltage pulses, which still remain proportional to the 
energy of the X-ray.  These signals are then sorted by voltage and their energies determined by 
a multichannel analyser.  The computer displays each incident X-ray for further data evaluation 
[176]. 
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2.6.1 SEM Experimental 
A small amount of sample is adhered to an aluminium specimen holder using carbon 
conductive tape.  It is important that the sample is electrically grounded to the sample holder 
to minimise specimen charging.  If the sample is non-conductive, it can be coated with a 1-5nm 
layer of gold.  This conductive layer increases beam stability and improves the image quality.  
In this experiment, the samples morphology was determined using an FEI Quanta 200 Scanning 
Electron Microscope with a secondary electron detector, Everhart-Thornly detector. 
This experimental was done to determine the elemental composition of the zeolite before and 
after ion-exchange.  Samples were coated with 1nm layer of gold and an average result was 
obtained from 5 area measurements (1-2 mm2). 
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2.7 BET Isotherm 
 
By BET (Brunauer, Emmett and Teller) the specific surface area of a sample is measured.  The 
samples are dried by purging nitrogen or by having elevated temperatures applied whilst being 
in a vacuum.  Unless otherwise instructed standard measurement points are taken at P/P0 of 
0.1, 0.2 and 0.3.  The volume of gas adsorbed is correlated to the total surface area of the 
particles including the surface pores [177].  Traditionally nitrogen is used as the adsorbate gas 
and the calculations are based on the Langmuir adsorption isotherm with introduction of a 
number of simplified assumptions: 
1. It is assumed that adsorption of the first adsorbate layer is to take place on an array of 
surface sites of uniform energy 
 
2. Then the second layer of adsorption can only take place on top of first, third on top of 
second, fourth on top of third, etc. When P=P0 (the saturated vapour pressure of the 
absorbate), an infinite number of layer form 
 
3. It is also assumed, that at equilibrium, the rates of condensation and evaporation are 
the same for each individual layer   
 
4. Finally, for the first adsorption layer the enthalpy of adsorption is the same as in the 
Langmuir case.  Therefore, the BET equation is formed from the summation of the 
amount adsorbed in all layers [Equation 2.8].  
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𝑷
𝑵𝒔(𝑷𝟎 − 𝑷)
=  
𝟏
𝑵𝑪
+ 
(𝑪 − 𝟏)
𝑵𝑪
 × 
𝑷
𝑷𝟎
 
 
Equation 2.8- The BET equation expressed in linear form   
 
Where  
C =  𝑒(𝑞𝑡−𝑞𝑜)/𝑅𝑇 (is a constant) 
N = monolayer adsorption amount  
Ns = Adsorption amount at the equilibrium pressure (P) [178]
 
      
2.7.1 BET Experimental 
Samples were degassed at 100°C under vacuum for 4 hours before being analysed by a 
Micromeritics ASAP 2010 Accelerate Surface Area and Porosimetry Sytem. 
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2.8 The Zeolites and Pharmaceuticals used in this Research Project  
 
The zeolites used as adsorbents are listed in table 2.3.  The zeolites [Table 2.3] were examined 
by the analytical techniques: XRD and IR, before the adsorption experiments, the results 
obtained are referred to as “zero hour mixing time”.  Standards for the adsorption 
experiments are performed by weighing out 0.25g of the zeolite [Table 2.3] and stirring with 
250 mL of water for 24 hours.  The standards are filtered out by using a centrifuge and dried in 
an oven before being analysed by XRD and IR. 
Table 2.3 – The names of the zeolites used and the company they were bought from 
 Zeolite Name Supplier 
Morrocan Clinoptilolite RS Minerals 
Japanese Clinoptilolite Newstone International 
Beta Hydrogen Alfa Chemicals 
Beta Ammonia Alfa Chemicals 
 
The pharmaceuticals used for the adsorption experiments were acetaminophen and Na-
ibuprofen.  The acetaminophen was supplied as a powder from the chemical company, Sigma 
Aldrich and was used to make a 250 mL aqueous solutions (0.05M).  Whereas, Nurofen Express 
tablets were obtained and crushed, in order to perform the Na-ibuprofen adsorption 
experiments with 250mL aqueous solutions of 0.005M.   
All the zeolites in table 2.3 were ion-exchanged with different cations in order to adjust the 
adsorption affinities.  For the ion-exchanges the following chemicals were used [Table2.4]. 
Table 2.4 – List of chemicals used for cation exchange and the company they were bought from 
Cation 
Obtained 
Chemical 
Used Supplier 
NH4
+ NH4 NO3 
Sigma 
Aldrich 
Cu (II) Cu SO4 . 6H2O 
Sigma 
Aldrich 
Fe(III) Fe SO4 .7H2O Alfa 
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Chapter 3: Results and Discussion 
 
3.1 Adsorption by Clinoptilolite 
 
Clinoptilolite, obtained from a mine in Morroco and supplied by the RS minerals, was used as 
the adsorbent for the first two adsorption experiments.  Solution i) was a 0.05M aqueous 
solution of acetaminophen and solution ii) was a 0.005M aqueous solution of Na-ibuprofen 
(Nurofen Express tablets).  The two mixtures were stirred for 24 hours at room temperature.  
The following analytical techniques were used to determine the affinity of clinoptilolite 
towards the two pharmaceuticals; HPLC, XRD and IR. 
3.1.1 HPLC Results 
The HPLC results obtained [Table 3.1.1], show the remaining concentrations of the drugs in 
solution and the percentage of drug adsorbed by clinoptilolite.  The results indicate 
clinoptilolite has a higher affinity towards the adsorption of Na-ibuprofen with a 53.93% drug 
uptake.  Despite the difference in percentage drug uptake, the results both show that 
clinoptilolite has the ability to adsorb both pharmaceuticals.  
 
Table 3.1.1 – Percentage of drug uptake by clinoptilolite determined by HPLC 
 
Drug Adsorbed Drug Uptake (%) Concentration Remaining in Solution (M) 
Acetaminophen 23.93 3.8x10-3 
Na-Ibuprofen 53.92 2.3x10-4 
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3.1.2 IR Results 
 
An IR spectroscopy scan of clinoptilolite before and after adsorption was performed, as seen in 
figure 3.1.1.  If any organic media was adsorbed within the pores there would be peaks shown 
in the spectra, however, there is little to no changes between the three spectra.  It was 
expected that the IR spectrum of clinoptilolite with acetaminophen to at least have an 
aromatic C=C bending at 1700-1500cm-1, along with an alcohol/phenol O-H stretch at 3550-
3200cm-1 to show that adsorption was successful.  Whereas, if Na-ibuprofen was adsorbed the 
IR spectrum was expected to show alkyl C-H stretches at 2950-2850cm-1 and an ester C=O 
stretch at 1750-1735cm-1.  However, as none of these peaks are displayed on the IR spectra it 
was concluded that the amount of drug was so small it could not be detected by the IR.  
Therefore, IR spectroscopy was not used as again as an analytical technique to detect 
pharmaceutical adsorption.  
 
Figure 3.1.1 – Comparison of IR Spectra of clinoptilolite before and after adsorption  
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3.1.3 Acetaminophen XRD Results  
 
It has been recognised that a change in the relative intensities of peak in a diffraction pattern 
can be due to molecules or ions occupying the pores of a zeolite.  The diffraction patterns of 
clinoptilolite before and after adsorption of acetaminophen differ slightly in the peak positions 
and relative intensities [Figure 3.1.2].   
The XRD patterns show a slight intensity change between 10 and 12° 2θ and between 20 and 
25° 2θ [Figure 3.1.2].  The greatest intensity change is displayed by peak 3 [Table 3.1.2] [Figure 
3.1.2] between XRD pattern A and C with peak 3 intensity decreasing by 24.11%.   XRD patterns 
B and A [Figure 3.1.2] also exhibited changes in their peak intensities, with peak 3 showing a 
11.5% decrease and peak 2 showing a 6.3% decrease.   
 
 
Figure 3.1.2 – Comparison of the XRD pattern of clinoptilolite adsorbed with acetaminophen against the 
XRD pattern of the clinoptilolite standard and the XRD pattern of clinoptilolite with zero mixing time.  
XRD patterns and peaks labelled with reference to table 3.1.2 
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Table 3.1.2 – Intensity changes of peak 2 and 3, relative to peak 1, for all for the three XRD patterns in 
Figure 3.1.2 
  
 
Peak 1 
Intensity 
(%) 
Peak 2 
Intensity 
(%) Peak 3 Intensity (%) 
Clinoptilolite with zero 
mixing time (A) 100.0 46.3 92.9 
Clinoptilolite standard (B) 100.0 44.6 62.4 
Clinoptilolite mixed with 
Acetaminophen (C) 100.0 47.6 70.5 
 
 
It is thought that the slight changes in peak intensities [Figure 3.1.2] [Table 3.1.2] are caused 
by the clinoptilolite adsorbing paracetamol into pores.  To support this idea the XRD patterns 
[Figure 3.1.2] are analysed by the software Topas using the Pawley fit method.  Pawley fit is a 
process in which the peaks observed in a XRD pattern are fitted by 2-theta values constrained 
by the size and symmetry of the unit cell.  The structural refinement of the unit cell gives an 
indication of the “best fit possible”.  By extracting the peak intensities before structural 
solution the software can determine the cell parameters [163]. A Pawley Fit can also 
determine any changes made to clinoptilolite unit cell parameters due to adsorption.  For the 
following results the parameters were refined with a Pawley fit, using a Chebyshev background 
function and pseudo-Voight peak shape function.  If the unit cell results from clinoptilolite 
change significantly after adsorption (the change is larger than the calculated error), then it is 
an indication that the drug has adsorbed into the pores rather than attached to the particles 
on the surface.   
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Figure 3.1.3 shows that a change in lattice parameter along the a or b-axis would have a 
greater effect on the size and structure of the pores, more so than a change in lattice 
parameter along the c-axis.  It is thought that any changes undertook by the c-axis would be 
caused from the a and b-axis adjusting to enable the drug to adsorb.  
 
Figure 3.1.3– Polyhedral image of clinoptilolite looking along the c-axis.   
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Figure 3.1.4 – Change in the unit cell lattice parameters of clinoptilolite before and after adsorption (1) 
clinoptilolite with no mixing, 2) clinoptilolite standard, 3) clinoptilolite mixed with acetaminophen for 24 
hours) 
 
 
The results in figure 3.1.4 show that the unit cells a, b and c all exhibit a significant 
change in their lattice parameters between samples 1 and 3.  However, only for the 
unit cell a and b and angle β show a lattice parameter change between samples 2 and 
3.  As all these changes mentioned above are larger than the calculated standard error, 
it suggests Clinoptilolites channel pores are expanding and contracting to 
accommodate Acetaminophen molecules.  
The Rwp values for the three Pawley fits [Figure 3.1.5] are shown in table 3.1.3. 
 
Table 3.1.3 – The Rwp values of the Pawley fits in figure 3.1.5 
 
XRD Pattern RWP % 
1) Clinoptilolite with zero mixing time  10.919 
2) Clinoptilolite standard  10.926 
3) Clinoptilolite mixed with Acetaminophen  11.423 
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The Rwp values are all similar for the samples in table 3.1.3.  With a fairly low average 
of 11.09% [Table 3.1.3] the Pawley fit results are not seen as a poor fit.  By using figure 
3.1.5 the impurities causing the poor fit can be identified.  This is because the tick 
marks at the bottom of each XRD pattern collected should match up with a peak 
[Figure 3.1.5].  If a peak with no matching blue line is visible, then an impurity has 
caused that particular peak.  The peak at 20-22° 2θ and the peak 34-36° 2θ [Figure 
3.1.5] are assumed to be caused from impurities in the original sample of clinoptilolite, 
as the peaks are visible in all three diffraction patterns.  There are no clear impurity 
peaks found in the XRD pattern “Clinoptilolite mixed with Acetaminophen for 24 
hours” [Figure 3.1.5] that can be thought to have been caused by acetaminophen and 
account for the slightly larger Rwp value [Table 3.1.3].        
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Figure 3.1.5 – Pawley fits obtained for 1) clinoptilolite with zero hours mixing 2) clinoptilolite standard 3) 
clinoptilolite mixed with acetaminophen for 24 hours 
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3.1.4 Na-Ibuprofen XRD Results  
 
The XRD patterns show a slight intensity change between 10 and 12° 2θ and between 
20 and 25° 2θ [Figure 3.1.6].  When comparing the 3 samples [Figure 3.1.6], the 
intensity of peak 2 relative to peak 1 decreases down the table [Table 3.1.4]; however, 
peak 3 does not follow this trend but does exhibit the biggest intensity change.  Peak 3 
is also the only peak to increase in intensity (relative to peak 1) [Figure 3.1.6] [Table 
3.1.4] as peak 3 in XRD pattern A increases by 13.2% in XRD pattern C.  
 
The diffraction patterns in figure 3.1.6 are also analysed using the Pawley fit method 
with the same refinement parameters used previously.  The Pawley fit results highlight 
that the unit cells a and b have the biggest parameter change.  The lattice parameters 
for unit cell a [Figure 3.1.8] shows the largest change between samples 1 and 3, as well 
as, sample 2 and 3, with an approximate decrease of 55.5%.  Unit cell b shows the next 
biggest change, along with the only increase in change, between samples 1 and 3 and 
samples 2 and 3.  Furthermore, the change for unit cell c between samples 2 and 3 are 
non-significant as they are within error.  The lattice parameter changes [Figure 3.1.8] 
could be caused by clinoptilolites main pore altering in size and structure to 
accommodate for the uptake of Na-ibuprofen, especially with figure 3.1.8 showing 
clinoptilolites a-axis decreasing and b-axis increasing between samples 2 and 3.    
80 | P a g e  
 
 
Figure 3.1.6 – Comparison of the XRD pattern of clinoptilolite adsorbed with Na-ibuprofen against the 
XRD pattern of the clinoptilolite standard and the XRD pattern of clinoptilolite with zero mixing time.  
XRD patterns and peaks labelled with reference to table 3.1.4 
 
 
 
 
Table 3.1.4 – Intensity changes of peak 2 and 3, relative to peak 1, for all for the three XRD patterns in 
Figure 3.1.6  
 
 
Peak 1 Intensity 
(%) 
Peak 2 Intensity 
(%) 
Peak 3 Intensity 
(%) 
Clinoptilolite with zero mixing time 
(A) 100.0 46.3 92.9 
Clinoptilolite standard (B) 100.0 44.6 62.4 
Clinoptilolite mixed with Na-
Ibuprofen (C) 100.0 42.2 71.9 
 
 
 
 
Table 3.1.5 – The Rwp values of the Pawley fits in figure 3.1.7 
 
XRD Pattern RWP % 
1) Clinoptilolite with zero mixing time 10.919 
2) Clinoptilolite standard  10.926 
3) Clinoptilolite mixed with Na-Ibuprofen  12.000 
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Figure 3.1.7 – Pawley fits for 1) clinoptilolite with zero hours mixing time 2) clinoptilolite standard 3) 
clinoptilolite with Na-ibuprofen 
 
 
There is an impurity present in the ‘Clinoptilolite mixed with Na-Ibuprofen for 24 hours” 
Pawley fit [Figure 3.1.7] at approximately 9° 2θ.   It was first thought the impurity was caused 
by Na-Ibuprofen, however, when comparing the diffraction pattern of “Clinoptilolite mixed 
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with Na-Ibuprofen” against the diffraction pattern of Na-Ibuprofen there were no matching 
peak.  Furthermore, the diffraction pattern database could not confirm the impurity peak to be 
caused by degradation products of Na-Ibuprofen such as:  hydratropic acid, 4-
ethylbenzaldehyde, 4-(1-carboxyethyl)benzoic acid, 1-(4-isobutylphenyl)-1-ethanol, 2-[4-(1-
hydroxy-2-methylpropyl)phenyl]propanoic acid, 1-isobutyl-4-vinylbenzene, 4-isobutylphenol 
[179].   
 
 
Figure 3.1.8– Change in the unit cell lattice parameters of clinoptilolite before and after adsorption (1) 
clinoptilolite with no mixing, 2) clinoptilolite standard, 3) clinoptilolite mixed with Na-ibuprofen for 24 
hours)  
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3.2 Adsorption by Japanese Clinoptilolite 
 
The first two adsorptions performed in section 3.1 were repeated with a different 
absorbent; clinoptilolite obtained from Japan.  As mentioned earlier natural zeolite can 
vary in elemental composition with change in geographical location.  A change in 
elemental composition could potentially affect clinoptilolite’s adsorption capacity.  
Therefore, further adsorption experiments were carried out with natural clinoptilolite 
obtained from a different location, with HPLC and XRD analysis to determine the 
affinity of the new clinoptilolite.   
 
3.2.1 HPLC Results 
 
The HPLC results attained [Table 3.2.1], show the remaining concentrations of the 
drugs in solution and the percentage of drug adsorbed by Japanese clinoptilolite.  
When comparing the HPLC result tables [Table 3.1.1] [Table 3.2.1] the results obtained 
show that both clinoptilolite samples have a higher affinity towards the adsorption of 
Na-Ibuprofen. 
 
The HPLC results also show that the Moroccan clinoptilolite has a higher adsorption 
capacity for acetaminophen compared to Japanese clinoptilolite [Table 3.1.1] [Table 
3.2.1].  Nevertheless, the overall HPLC results show that both clinoptilolite samples 
have the ability to adsorb acetaminophen and Na-ibuprofen [Table 3.1.1] [Table 3.2.1]. 
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Table 3.2.1 – Percentage of drug uptake by Japanese clinoptilolite determined by HPLC 
 
Drug Adsorbed Drug Uptake (%) Concentration Remaining in Solution (M) 
Acetaminophen 12.64 4.4x10-3 
Na-Ibuprofen 54.11 2.3x10-4 
 
3.2.2 XRD Results for Acetaminophen 
 
 
Figure 3.2.1 – Comparison of the XRD pattern of Japanese clinoptilolite adsorbed with acetaminophen 
against the XRD pattern of the Japanese clinoptilolite standard and the XRD pattern of Japanese 
clinoptilolite with zero mixing time.  XRD patterns and peaks labelled with reference to table 3.2.2 
 
 
Table 3.2.2 – Intensity changes of peak 2, 3 and 4, in respect to peak 1, for all for the three XRD patterns 
in Figure 3.2.1 
 
 Peak 1 
Intensity 
(%) 
Peak 2 
Intensity 
(%) 
Peak 3 
Intensity 
(%) 
Peak 4 
Intensity 
(%) 
Japanese Clinoptilolite with zero 
mixing time (A) 
100.0 46.4 86.2 37.2 
Japanese Clinoptilolite standard 
(B) 
100.0 47.7 56.0 24.0 
Japanese Clinoptilolite mixed with 
Acetaminophen (C) 
100.0 49.1 65.6 94.0 
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Figure 3.2.2 – Change in the unit cell lattice parameters of Japanese clinoptilolite before and after 
adsorption (1) Japanese clinoptilolite with no mixing, 2) Japanese clinoptilolite standard, 3) Japanese 
clinoptilolite mixed with acetaminophen for 24 hours) 
 
The diffraction patterns of Japanese clinoptilolite before and after adsorption of 
acetaminophen are shown in figure 3.2.1.  The XRD patterns show a slight intensity 
change between 10 and 12° 2θ and between 20 and 30° 2θ [Figure 3.2.1].  The greatest 
intensity change is displayed by peak 4 [Table 3.2.2] [Figure 3.2.1] between XRD 
pattern A and C with peak intensity increasing by 60.43%.   XRD patterns from figure 
3.1 display less changes in peak intensity changes than those in figure 3.2.1, which is 
interesting when you compare them to the HPLC results [Table 3.2.1] [Table 3.1.1].  It 
would be expected that the diffraction patterns in figure 3.2.1 would have had less 
peak intensity changes [Table 3.2.2] than figure 3.1.2 [Table 3.1.2], as less 
acetaminophen was absorbed according to the HPLC results obtained [Table 3.2.1] 
[Table 3.1.1].   
The Pawley fit results show that the only significant lattice parameter changes were 
between samples 2 and 3 along the c-axis and for unit cell angle be, as the recorded 
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changes are outside of the estimated error [Figure 3.2.2].  The results could also be 
interpreted to show no change in pore size due to low uptake of acetaminophen [Table 
3.2.1], as there is are no significant changes displayed by unit cells a and b.       
 
Table 3.2.3 – The Rwp values of the Pawley fits in figure 3.2.3 
 
XRD Pattern RWP % 
1) Japanese Clinoptilolite with zero mixing 
time  12.964 
2) Japanese Clinoptilolite standard 12.391 
3) Japanese Clinoptilolite mixed with 
Acetaminophen 15.297 
 
 
 
With the Rwp values being relatively low [Table 3.2.3], it shows the XRD patterns fit 
relatively well to the structural model, however, table 3.2.3 displays the highest Rwp 
value recorded so far.  It was originally thought that adsorbed acetaminophen had 
caused the high Rwp but with visual aid [Figure 3.2.3] it was clear that the impurity was 
not acetaminophen, as all the noticeable unticked peaks are present in all three 
Pawley fits.          
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Figure 3.2.3 –  Pawley fits obtained for 1) Japanese clinoptilolite mixed for 0 hours 2) Japanese 
clinoptilolite standard 3) Japanese clinoptilolite mixed with acetaminophen for 24 hours 
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3.2.3 XRD Results for Na-Ibuprofen 
 
The unit cells a and b [Figure 3.2.5] have similar results to figure 3.2.2 with lattice 
parameter changes between samples 2 and 3 being within error.  However, if the drug 
was adsorbed into the pores, it was assumed that there would be significant changes 
seen in figure 3.2.5, especially as there was a high percentage drug uptake of 54.11% 
[Table 3.2.1].  However, as there is no significant lattice parameter changes, it can be 
assumed the drug is small enough to not alter the pore size shape, or the drug has 
adsorbed to the samples surface.    
The Pawley fit for “Japanese clinoptilolite mixed with Na-Ibuprofen for 24 hours” 
[Figure 3.2.6] has the same impurity as the “Clinoptilolite mixed with Na-Ibuprofen for 
24 hours” [Figure 3.1.7] at approximately 9° 2θ.  As this impurity is not seen when 
acetaminophen is used, therefore, it can be assumed Na-ibuprofen is somehow 
causing this peak to appear. 
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Figure 3.2.4 – Comparison of the XRD pattern of Japanese clinoptilolite adsorbed with Na-ibuprofen 
against the XRD pattern of the Japanese clinoptilolite standard and the XRD pattern of Japanese 
clinoptilolite with zero mixing time.  XRD patterns and peaks labelled with reference to table 3.2.4 
 
 
 
 
Table 3.2.4 – Intensity changes of peak 2, 3 and 4, relative to peak 1, for all of the three XRD patterns in 
Figure 3.2.4 
 
 Peak 1 
Intensity 
(%) 
Peak 2 
Intensity 
(%) 
Peak 3 
Intensity 
(%) 
Peak 4 
Intensity 
(%) 
Japanese Clinoptilolite with zero 
mixing time (A) 
100.0 46.4 86.2 66.2 
Japanese Clinoptilolite standard 
(B) 
100.0 47.7 56.0 45.9 
Japanese Clinoptilolite mixed with 
Na-Ibuprofen(C) 
100.0 45.4 57.0 42.3 
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Figure 3.2.5 – Change in the unit cell lattice parameters of Japanese clinoptilolite before and after 
adsorption (1) Japanese clinoptilolite with no mixing, 2) Japanese clinoptilolite standard, 3) Japanese 
clinoptilolite mixed with Na-ibuprofen for 24 hours)  
 
 
 
Table 3.2.5 – The Rwp values of Pawley fits in figure 3.2.6 
 
XRD Pattern RWP % 
1) Japanese Clinoptilolite with zero mixing 
time  12.964 
2) Japanese Clinoptilolite standard  12.391 
3) Japanese Clinoptilolite mixed with Na-
Ibuprofen 12.488 
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Figure 3.2.6 – Pawley fits obtained for 1) Japanese clinoptilolite mixed for 0 hours 2) Japanese 
clinoptilolite Standard 3) Japanese clinoptilolite mixed with Na-ibuprofen for 24 hours 
 
 
 
 
 
 
 
92 | P a g e  
 
 
3.3 Ion-Exchange of Clinoptilolite 
 
 
In the last decade, natural zeolites have attracted great attention as ecologically advantageous 
and affordable materials that are abundant and inexpensive.  Importantly, they can be 
modified to adjust and even tailor their adsorptive possibilities.  Rakić et al. [155] ion-
exchanged clinoptilolite with the following heavy metals: Mn(II), Ni(II), Cu(II), and Zn(II), as 
they formed stable complexes with N and O-donor groups present in their chosen 
pharmaceuticals; salicyclic acid, acetylsalicyclic acid and atenolol.  The results showed 
clinoptilolite ion-exchanged with Cu to have a high adsorption capacity.    For this reason, 
Japanese clinoptilolite and Moroccan clinoptilolite were ion-exchanged with Fe(III), Cu(II) and 
NH4
+
.   Both clinoptilolite samples were ion-exchanged with NH4
+
, as they form stable bonds 
with the hydrogen atoms present in both pharmaceuticals.  
 
3.3.1 SEM-EDX Results  
 
Chemical analysis of the clinopilolite samples were performed, before and after ion-exchange, 
using a scanning electron microscope in conjunction with an energy-dispersive X-ray 
spectroscopy.  An average elemental composition of the samples was obtained by a data 
collection at 5 different areas on the samples surface.  The results attained confirm that all ion-
exchanges were successful [Table 3.3.1] [Table 3.3.2].   
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Table 3.3.1 – Results of EDX analyses for each of the four clinoptilolite samples in wt%.  The chemical 
compositions correspond to average values obtained from 5 area measurements (1-2mm
2
) 
 
Elements 
Detected 
Results for 
Clinoptilolite 
(Wt%) 
Clinoptilolite Ion-
exchanged with 
Copper (Wt%) 
Clinoptilolite Ion-
exchanged with 
Iron (Wt%) 
Clinoptilolite Ion-
exchanged with 
Ammonia (Wt%) 
Si 30.5 31.9 27.4 33.3 
Al 6.9 6.7 5.6 7.1 
O 43.6 41.8 44.5 43.9 
Fe 2.2 3.0 6.6 1.1 
Cu 1.0 5.9 0.9 0.6 
N 8.2 7.3 11.7 12.2 
Na 1.8 0.4 0.5 0.6 
Ca 1.2 0.8 0.83 0.2 
K 2.7 2.2 1.8 1.1 
 
 
 
 
Table 3.3.2- Results of EDX analyses for each of the four Japanese clinoptilolite samples in wt%.  The 
chemical compositions correspond to average values obtained from 5 area measurements (1-2mm
2
) 
 
Elements 
Detected 
Results for 
Japanese 
Clinoptilolite 
(Wt%) 
Japanese 
Clinoptilolite Ion-
exchanged with 
Copper (Wt%) 
Japanese 
Clinoptilolite Ion-
exchanged with 
Iron (Wt%) 
Japanese 
Clinoptilolite Ion-
exchanged with 
Ammonia (Wt%) 
Si 33.3 31.7 32.6 33.8 
Al 6.5 6.5 6.6 6.5 
O 43.1 41.5 43.5 44.2 
Fe 1.3 1.4 4.3 0.9 
Cu 0.8 6.1 0.7 0.7 
N 10.0 9.5 10.9 12.0 
Na 1.9 0.7 0.8 0.7 
Ca 0.7 0.6 0.6 0.3 
K 2.5 2.0 2.1 0.9 
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3.3.2 HPLC Results 
Importantly, these results [Table 3.3.3 – Table 3.3.6] clearly show that adsorption 
capacity of clinoptilolites can be enhanced by the addition of different ions: all cation-
exchanged samples adsorb higher amount of Na-ibuprofen then the parent zeolite.  
However, contrary to Na-ibuprofen adsorption [Table 3.3.3- Table 3.3.6], the 
acetaminophen exhibited lower adsorption capacities then the original clinoptilolite 
[Table 3.3.1].  The variances in drug uptake demonstrates how the presence of a 
certain cation influences the adsorption capacity of the zeolite and how zeolites can be 
modified towards uptake of a particular pharmaceutical.  It is also worth mentioning 
that the best adsorptions achieved were from the Cu-exchanged clinoptilolites [Table 
3.3.3 – Table 3.3.6], which was also observed by Rakić et al [155]. 
Table 3.3.3 – Percentage uptake of Acetaminophen by clinoptilolite samples determined by HPLC 
 
 
 
 
Drug 
Uptake (%) 
Concentration Remaining in 
Solution (M) 
Clinoptilolite ion-exchanged with Cu 21.66 3.92x10-3 
Clinoptilolite ion-exchanged with Fe 10.97 4.45x10-3 
Clinoptilolite ion-exchanged with 
NH4 10.65 4.47x10
-3 
 
Table 3.3.4 – Percentage uptake of Acetaminophen by Japanese clinoptilolite samples determined by 
HPLC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Drug 
Uptake (%) 
Concentration Remaining in 
Solution (M) 
Japanese Clinoptilolite ion-
exchanged with Cu 15.04 4.25x10-3 
Japanese Clinoptilolite ion-
exchanged with Fe 13.11 4.34x10-3 
Japanese Clinoptilolite ion-
exchanged with NH4 14.19 4.29x10
-3 
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Table 3.3.5 – Percentage uptake of Na-ibuprofen by clinoptilolite samples determined by HPLC 
 
 
 
 
Drug 
Uptake 
(%) 
Concentration Remaining in 
Solution (M) 
Clinoptilolite ion-exchanged with 
Cu 60.87 1.96x10-4 
Clinoptilolite ion-exchanged with 
Fe 55.07 2.46x10-4 
Clinoptilolite ion-exchanged with 
NH4 57.77 2.11x10
-4 
 
 
Table 3.3.6 – Percentage uptake of Na-ibuprofen by clinoptilolite samples determined by HPLC 
 
 
 
 
Drug 
Uptake 
(%) 
Concentration Remaining in 
Solution (M) 
Japanese Clinoptilolite ion-
exchanged with Cu 60.70 1.97x10-4 
Japanese Clinoptilolite ion-
exchanged with Fe 50.77 2.46x10-4 
Japanese Clinoptilolite ion-
exchanged with NH4 52.48 2.38x10
-4 
 
 
3.3.3 XRD Results for Cu-exchanged Clinoptilolite Samples  
 
A significant change in the XRD pattern C [Figure3.3.2] is seen between 5 and 10° 2θ 
and 25 and 30° 2θ, with the addition of 4 new peaks.  The addition of the same 4 peaks 
is also seen in [Figure 3.3.3] but there are no additional peaks present in the 
acetaminophen samples.  It was originally thought that the additional peaks were 
caused by Na-ibuprofen precipitating from solution, however, when compared to the 
Na-ibuprofen XRD pattern it was apparent the 4 peaks were not caused from adsorbed 
Na-ibuprofen [Figure 3.3.2] [Figure 3.3.3].  
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Identification of the substance causing all the new peaks was not possible, however, 
the diffraction pattern for copper propanoate matched the peak at approximately 6° 
2θ [Figure 3.3.5] [Figure 3.3.2].  The blue tick marks in figure 3.3.5 represent peaks 
from the copper propanoate diffraction pattern.  It is thought that during the 
adsorption experiment, Na-ibuprofen has decomposed to form a propanoate ion 
which forms a complex with the copper ions, which has caused peak 2 [Figure 3.3.2] 
[Figure 3.3.3].  It can be assumed that the other 3 peaks found in Na-ibuprofen 
adsorption diffraction patterns [Figure 3.3.2] [Figure 3.3.3] are caused by other 
degradation products of Na-ibuprofen forming complexes with clinoptilolite cations.    
 
For the acetaminophen adsorptions, the changes in peak intensities are highlighted in 
figure 3.3.1 and figure 3.3.4.  The Cu-exchanged, Moroccan, clinoptilolite displays the 
largest intensity changes [Table3.3.8] in comparison to the intensity changes 
experienced by the Cu-exchanged, Japanese, clinoptilolite [Table 3.3.7].  Which relates 
to the HPLC results obtained from the acetaminophen adsorptions [Table 3.3.3] [Table 
3.3.4], as the variance in intensity changes in table 3.3.8 could be caused from the 
higher uptake of acetaminophen [Table3.3.3].         
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Figure 3.3.1 – Comparison of the XRD pattern of clinoptilolite Cu-exchanged adsorbed with 
acetaminophen against the XRD pattern of the clinoptilolite Cu-exchanged standard, and the XRD 
pattern of clinoptilolite with zero mixing time. XRD patterns and peaks labelled with reference to table 
3.3.8 
 
 
Figure 3.3.2 – Comparison of the XRD pattern of clinoptilolite Cu-exchanged adsorbed with Na-ibuprofen 
against the XRD pattern of the clinoptilolite Cu-exchanged standard, the XRD pattern of clinoptilolite 
with zero mixing time and the XRD pattern of Na-ibuprofen.   
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Table 3.3.7 – Intensity changes of peak 2, 3 and 4, relative to peak 1, for all of the three XRD patterns in 
Figure 3.3.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.3.8 – Intensity changes of peak 2, 3 and 4, relative to peak 1, for all of the three XRD patterns in 
Figure 3.3.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Peak 1 
Intensity 
(%) 
Peak 2 
Intensity (%) 
Peak 3 
Intensity (%) 
Japanese Clinoptilolite, Cu-
exchanged, with zero mixing time 
(A) 
100 37.3 74.4 
Japanese Clinoptilolite, Cu-
exchanged, standard (B) 
100 35.4 71.5 
Japanese Clinoptilolite, Cu-
exchanged, mixed with 
Acetaminophen (C) 
100 36.3 71.7 
 
Peak 1 
Intensity 
(%) 
Peak 2 
Intensity (%) 
Peak 3 
Intensity (%) 
Clinoptilolite, Cu-exchanged, with 
zero mixing time (A) 
100 35.8 65.8 
Clinoptilolite, Cu-exchanged, 
standard (B) 
100 39.9 84 
Clinoptilolite, Cu-exchanged, mixed 
with Acetaminophen (C) 
100 29.8 71.8 
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Figure 3.3.3 – Comparison of the XRD pattern of Japanese clinoptilolite Cu-exchanged adsorbed with Na-
ibuprofen against the XRD pattern of the Japanese clinoptilolite Cu-exchanged standard, the XRD pattern 
of Japanese clinoptilolite with zero mixing time and the XRD pattern of Na-ibuprofen.   
 
 
 
Figure 3.3.4 – Comparison of the XRD pattern of Japanese clinoptilolite Cu-exchanged adsorbed with 
acetaminophen against the XRD pattern of the Japanese clinoptilolite Cu-exchanged standard, and the 
XRD pattern of Japanese clinoptilolite with zero mixing time. XRD patterns and peaks labelled with 
reference to table 3.3.7 
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Figure 3.3.5 – Identification of new peaks found in the diffraction pattern of Japanese clinoptilolite Cu-
exchanged adsorbed with Na-ibuprofen.  The diffraction pattern of Copper propionate is represented by 
the blue lines and the green lines represent the diffraction pattern from clinoptilolite 
 
 
 
 
 
Results from figure 3.3.6 to figure 3.3.9 all show substantial change in lattice 
parameters between samples 2 and 3 for unit cell axis a and b.  This change in lattice 
parameters for the a and b-axis could be from the pores altering shape to 
accommodate the drug inside, particularly as the Cu-exchange Clinoptilolite samples 
have achieved highest drug uptake recorded so far [Tables 3.3.3 – Table 3.3.6].        
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Figure 3.3.6 – Change in the unit cell lattice parameters of Cu-exchanged clinoptilolite before and after 
adsorption (1) Cu-exchanged clinoptilolite with no mixing, 2) Cu-exchanged, clinoptilolite standard, 3) Cu-
exchanged, clinoptilolite mixed with acetaminophen for 24 hours 
 
 
 
 
Figure 3.3.7 – Change in the unit cell lattice parameters of Cu-exchanged clinoptilolite before and after 
adsorption (1) Cu-exchanged clinoptilolite with no mixing, 2) Cu-exchanged, clinoptilolite standard, 3) Cu-
exchanged, clinoptilolite mixed with Na-ibuprofen for 24 hours 
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Figure 3.3.8 – Change in the unit cell lattice parameters of Cu-exchanged, Japanese clinoptilolite before 
and after adsorption (1) Cu-exchanged, Japanese clinoptilolite with no mixing, 2) Cu-exchanged, 
Japanese clinoptilolite standard, 3) Cu-exchanged, Japanese clinoptilolite mixed with acetaminophen for 
24 hours 
 
 
Figure 3.3.9 – Change in the unit cell lattice parameters of Cu-exchanged, Japanese clinoptilolite before 
and after adsorption (1) Cu-exchanged, Japanese clinoptilolite with no mixing, 2) Cu-exchanged, 
Japanese clinoptilolite standard, 3) Cu-exchanged, Japanese clinoptilolite mixed with Na-ibuprofen for 24 
hours 
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Table 3.3.9 - The Rwp values of the Pawley fits in figure 3.3.11 
 
XRD Pattern RWP % 
Clinoptilolite, Cu-exchanged, with zero mixing time (1)  9.018 
Clinoptilolite, Cu-exchanged, standard (2) 6.811 
Clinoptilolite, Cu-exchanged, mixed with Acetaminophen (3) 8.518 
Clinoptilolite, Cu-exchanged, mix with Na-Ibuprofen (4) 12.129 
 
Table 3.3.10 - The Rwp values of the Pawley fits in figure 3.3.12 
 
XRD Pattern RWP % 
Japanese Clinoptilolite, Cu-exchanged, with zero mixing time (1) 11.181 
Japanese Clinoptilolite, Cu-exchanged, standard (2) 9.499 
Japanese Clinoptilolite, Cu-exchanged, mixed with 
Acetaminophen (3) 
11.842 
Japanese Clinoptilolite, Cu-exchanged, mix with Na-Ibuprofen 
(4) 16.991 
 
The highest Rwp values recorded for all Cu-exchanged samples are from both 
clinoptilolite samples absorbed with Na-ibuprofen [Table 3.3.9] [Table 3.3.10].  This is 
due to the impurity peaks between 5 and 10° 2θ and 25 and 30° 2θ along with the high 
background noise [Figure 3.3.10] [Figure 3.3.11].   
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Figure 3.3.10 – Pawley fits for 1) clinoptilolite, Cu-exchanged, 0 hours mixing time, 2) clinoptilolite, Cu-
exchanged, standard, 3) clinoptilolite, Cu-exchanged, 24 hour mix with acetaminophen, 4) clinoptilolite, 
24 hour mix with Na-ibuprofen 
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Figure 3.3.11 - Pawley fits for 1) Japanese clinoptilolite, Cu-exchanged, 0 hours mixing time, 2) Japanese 
Clinoptilolite, Cu-exchanged, standard, 3) Japanese clinoptilolite, Cu-exchanged, 24 hour mix with 
acetaminophen, 4) Japanese clinoptilolite, 24 hour mix with Na-ibuprofen 
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3.4 Adsorption using Zeolite Beta 
 
Adsorption experiments were performed exactly as described in section 3.3, however, zeolite 
beta hydrogen (BEA-H) and zeolite beta ammonia (BEA-NH4) were used as the adsorbent.  BEA 
zeolites were selected as the adsorbents due to its large pores and defective structures, both 
characteristic appear to be ideal for the adsorption of drugs with moderate molecular 
dimensions.  
 
3.4.1 Ion-exchange  
 
In this study BEA-H and BEA-NH4 were used as the initial absorbents.  The only difference 
between the two starting absorbents were the cations present.  Both zeolites were ion-
exchanged with Fe(III), Cu(II) and NH4
+.  The ion-exchanges were performed on both zeolites 
because the starting cations may have different binding affinities towards the zeolite, thus, 
after ion-exchange the initial zeolites may have different quantities of the new cation.  The 
difference in the amount of cations has the potential to effect the zeolites adsorption capacity.  
However, it is also possible that after ion-exchange the two initial zeolites to be co-ordinated 
with similar amounts of the same cation.  If this were the case, it is thought the adsorption 
results should be similar.   
Chemical analysis of the BEA samples was performed, before and after ion-exchange, using an 
SEM-EDX.  An average elemental composition of the samples was obtained by a data collection 
at 5 different areas on the samples surface.  The results attained confirm that all ion-
exchanges were successful [Table 3.4.1] [Table 3.4.2]. 
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Table 3.4.1- Results of EDX analyses for each of the four BEA-H samples in wt%.  The chemical 
compositions correspond to average values obtained from 5 area measurements (1-2mm
2
) 
 
Elements 
detected 
Results for 
BEA-H (Wt 
%) 
Results for BEA-H, 
Ion-exchanged with 
Cu (Wt %) 
Results for BEA-H, 
Ion-exchanged with 
Fe (Wt %) 
Results for BEA-H, 
Ion-exchanged with 
NH4 (Wt %) 
Si 46.4 41.7 40.5 38.5 
Al 0.8 0.6 2.4 1.6 
O 42.8 46.9 46.4 41.8 
Fe 0.5 0.2 2.8 1.4 
Cu 0.8 0.6 0.7 3.2 
N 8.8 10.0 8.9 15.5 
 
Table 3.4.2- Results of EDX analyses for each of the three BEA-NH4 samples in wt%.  The chemical 
compositions correspond to average values obtained from 5 area measurements (1-2mm
2
) 
 
Elements 
detected 
Results for BEA-
NH4 (Wt %) 
Results for BEA-NH4, Ion-
exchanged with Cu (Wt %) 
Results for BEA-NH4, Ion-
exchanged with Fe  
(Wt %) 
Si 40.5 36.5 34.8 
Al 3.8 3.2 2.7 
O 45.3 45.5 43.9 
Fe 0.4 0.3 7.2 
Cu 0.7 3.6 0.9 
N 9.4 10.9 10.5 
 
 
EDX results showed that BEA-NH4 ion-exchanged to a greater extent with Cu(II) and Fe(III) 
more so than BEA-H [Table 3.4.1] [Table 3.4.2].  The results also showed that ion-exchange 
with Fe(III) was more successful with BEA-NH4 than BEA-H.  As 7.2% Fe was detected in BEA-
NH4 ion-exchange with Fe(III) compared to the 2.8% detected in the BEA-H ion-exchanged with 
Fe (III) [Table 3.4.1] [Table 3.4.2].  Additionally, the Fe-exchanged sample for BEA-NH4 is above 
the ion-exchange capacity.  The higher quantity is thought to be caused by the formation of 
finely dispersed intra-zeolite ferric oxide clusters.       
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3.4.2 HPLC Results 
 
The HPLC results obtained [Table 3.4.5] [Table 3.4.6], show that all the BEA samples have 
similar adsorption affinities towards acetaminophen of approximately 12%.  This is also the 
case for the Na-ibuprofen adsorptions, with all the BEA samples absorbing approximately 23% 
[Table 3.4.3] [Table 3.4.4].  As there is little variance in drug uptake, it can be assumed that 
pharmaceuticals in question, can bind to each cation with similar binding affinities. 
 
The highest percentage uptake of acetaminophen and Na-ibuprofen is exhibited by all BEA 
samples ion-exchanged with Fe [Table 3.4.3 - Table 3.4.6].  Furthermore, the HPLC results 
show that BEA has a higher affinity towards Na-ibuprofen [Table 3.4.3] [Table 3.4.4] compared 
to acetaminophen [Table 3.4.5] [Table 3.4.6], this was also the case for all the clinoptilolite 
adsorptions [Table 3.0] [Table 3.2.1] [Table 3.3.3] [Table 3.3.4] [Table 3.3.5] [Table 3.3.6].  
However, BEA showed relatively low uptake of Na-Ibuprofen, with an approximate adsorption 
of 23% [Table 3.4.3] [Table 3.4.4], compared to the 60% uptake displayed by Clinoptilolite 
[Table 3.3.5] [Table 3.3.6].    
  
Furthermore, the HPLC results show that the BEA-NH4 samples ion-exchanged with Fe, 
achieved higher drug uptake for both pharmaceuticals [Table 3.4.4] [Table 3.4.6], when 
compared to the adsorption results achieved by the BEA-H samples ion-exchanged with Fe 
[Table 3.4.3] [Table 3.4.5].  It is thought that this slight difference in adsorptions is due to the 
quantities of Fe cations present.  As the EDX results show [Table 3.4.1] [Table 3.4.2] that after 
ion-exchange with Fe, that there are more Fe cations present in the BEA-NH4 sample than the 
BEA-H sample.  Therefore, it is thought that BEA-NH4 achieved higher adsorption results [Table 
3.4.4] [Table 3.4.6] as it contained more Fe cations for the drugs to bind to. 
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Table 3.4.3 – Percentage uptake of Na-Ibuprofen by Beta Hydrogen (X) samples determined by HPLC 
 
  
Drug uptake 
(%) 
Concentration 
Remaining 
Beta Hydrogen (X) 23.97 3.802x10-4 
X, Ion-exchanged with Cu 21.84 3.908x10-4 
X, Ion-exchanged with Fe 25.60 3.720x10-4 
X, Ion-exchanged with 
NH4 22.02 3.899x10
-4 
 
 
Table 3.4.4 – Percentage uptake of Na-Ibuprofen by Beta Ammonia (Y) samples determined by HPLC 
 
  
Drug uptake 
(%) 
Concentration 
Remaining 
Beta Ammonia (Y) 21.90 3.905x10-4 
Y, Ion-exchanged with Cu 22.51 3.875x10-4 
Y, Ion-exchanged with Fe 28.93 3.554x10-4 
 
 
Table 3.4.5 – Percentage uptake of Acetaminophen by Beta Hydrogen (X) samples determined by HPLC 
 
  
Drug uptake 
(%) 
Concentration 
Remaining 
Beta Hydrogen (X) 11.35 4.43x10-3 
X, Ion-exchanged with Cu 11.12 4.44x10-3 
X, Ion-exchanged with Fe 13.77 4.31x10-3 
X, Ion-exchanged with 
NH4 
11.53 4.42x10-3 
 
 
Table 3.4.6 – Percentage uptake of Acetaminophen by Beta Ammonia (Y) samples determined by HPLC 
 
  
Drug uptake 
(%) 
Concentration 
Remaining 
Beta Ammonia (Y) 13.90 4.31x10-3 
Y, Ion-exchanged with Cu 12.68 4.37x10-3 
Y, Ion-exchanged with Fe 14.43 4.28x10-3 
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3.4.3 XRD results for BEA-NH4 Ion-exchanged with Fe  
 
The pore size of BEA is big enough to accommodate acetaminophen and Na-ibuprofen, 
therefore, BEA pores would not express any structure change during pharmaceutical 
adsorption.  The changes in lattice parameters between the standard sample (2) and the drug 
adsorbed sample (3) [Figure 3.4.1] [Figure 3.4.2] are all within calculated error.  The error is 
caused by defects site (Si(OH)x groups) present in BEAs framework.  Therefore, it cannot be 
confirmed that no substantial changes have occurred to the BEA unit cells [Figure 3.4.1] [Figure 
3.4.2].  
 
Figure 3.4.1– Change in the unit cell lattice parameters of Fe-exchanged, BEA-NH4 before and after 
adsorption (1) Fe-exchanged, BEA-NH4 with no mixing, 2) Fe-exchanged, BEA-NH4 standard, 3) Fe-
exchanged, BEA-NH4 mixed with acetaminophen for 24 hours 
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Figure 3.4.2– Change in the unit cell lattice parameters of Fe-exchanged, BEA-NH4 before and after 
adsorption (1) Fe-exchanged, BEA-NH4 with no mixing, 2) Fe-exchanged, BEA-NH4 standard, 3) Fe-
exchanged, BEA-NH4 mixed with Na-ibuprofen for 24 hours 
  
 
 
Table 3.4.7 - The Rwp values of the Pawley fits in figure 3.4.3 
 XRD Pattern RWP % 
BEA-NH4 , Fe-exchanged, with zero mixing time (1)  5.676 
BEA-NH4 , Fe-exchanged, standard (2) 5.557 
BEA-NH4 , Fe-exchanged, mixed with Acetaminophen (3) 5.522 
BEA-NH4 , Fe-exchanged, mix with Na-Ibuprofen (4) 13.529 
 
 
The Rwp values for “BEA-NH4, Fe-exchanged, mixed with Na-Ibuprofen” has the highest Rwp 
value of 13.529% [Table 3.4.7].  It is still seen as a “good fit”, however, all the other Rwp values 
in table 3.4.7 are all a lot lower with approximately 5%.  It is thought the error is due to the 
Pawley fit trying to match the impurity peaks to BEA peaks.  This is very clear at around 10° 2θ 
[Figure 3.4.3] in the Pawley fit for “3) BEA-NH4, Fe-exchanged, mixed with Na-Ibuprofen” as 
the BEA peak is too narrow to be matched with the impurity peak. 
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Figure 3.4.3– Pawley fits obtained for (1) Fe-exchanged, BEA-NH4 with no mixing, 2) Fe-exchanged, BEA-
NH4 standard, 3) Fe-exchanged, BEA-NH4 mixed with acetaminophen for 24 hours and 4) Fe-exchanged, 
BEA-NH4 mixed with Na-ibuprofen for 24 hours 
 
 
 
113 | P a g e  
 
Identification of the substance causing the new peak at approximately 9° 2θ [Figure 3.4.3] is 
thought to be copper acetate hydroxide hydrate.  The blue lines in figure 3.4.4 represent the 
peaks from the copper acetate hydroxide hydrate diffraction pattern.  Figure 3.4.4 shows three 
peaks that match up, however, the intensity for blue line at approximately 28° 2θ is not an 
exact match.  It is thought that copper acetate hydroxide hydrate is another degradation 
product formed from Na-ibuprofen, similar to the copper propanoate ion identified earlier 
[3.3.5].  Although this species is co-ordinated to copper, it is possible it could be co-ordinated 
to the iron cat ions.  
 
 
Figure 3.4.4 – Identification of new peaks found in the diffraction pattern of Na-Ibuprofen adsorbed by 
BEA-NH4, ion-exchanged with Fe. The diffraction pattern of copper acetate hydroxide hydrate is 
represented by the blue lines 
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Figure 3.4.5 – Comparison of the diffraction pattern of BEA-NH44 Fe-exchanged adsorbed with Na-
ibuprofen against the XRD pattern of BEA-NH4, Fe-exchanged, standard, the diffraction pattern of BEA-
NH4, Fe-exchanged, with zero mixing time, and the diffraction pattern of Na-ibuprofen 
 
 
The XRD diffraction pattern for of BEA-NH4 Fe-exchanged adsorbed with acetaminophen 
[Figure 3.4.5] does not contain any peaks which are thought to be caused by acetaminophen 
related impurities.  However, the peak present between 20 and 25° 2θ noticeably varies with 
its peak intensities before and after adsorption [Figure 3.4.5] that could be caused by the 
uptake of acetaminophen. 
The Rwp value for “BEA-NH4, Fe-exchanged, mixed with acetaminophen (3)” shows the Pawley 
fit to be a relatively good [Table 3.4.7].  Along with figure 3.4.3 it shows there is no impurity 
peaks in the diffraction pattern to be caused by acetaminophen.  The low uptake of 
acetaminophen at 14.43% [Table 3.4.6] could be the reason why there are only slight peak 
intensity variances [Figure 3.4.5]. 
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Figure 3.4.6 – Comparison of the diffraction pattern of BEA-NH4 Fe-exchanged adsorbed with 
Acetaminophen against the diffraction pattern of BEA-NH4, Fe-exchanged, standard and the diffraction 
pattern of BEA-NH4, Fe-exchanged, with zero mixing time 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.5 29-Si MAS NMR Results 
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29-Si MAS NMR was performed to determine the silicon to aluminium ratio (Si:Al) of the 
following zeolites; clinoptilolite, Japanese clinoptilolite, BEA-H and BEA-NH4 were determined 
using 29-Si MAS NMR.  The results are tabulated below in table 3.5.1.  
 
Table 3.5.1. – Si:Al results for the four initial zeolites as supplied without modification 
 
Zeolite Si:Al 
Clinoptilolite 3.75 
Japanese Clinoptilolite  4.48 
BEA-H 3.43 
BEA-NH4 3.21 
 
The Si:Al ratio can be used to determine the number of cations in the zeolites framework.  As 
each Al atom brings one negative charge to be compensated by the adequate cation, thus, the 
Si:Al ratio strongly influences the adsorptive properties of zeolites. 
 
The 29-Si MAS NMR results [Table 3.5.1] show the clinoptilolite samples to have a higher Si:Al 
ratio than the BEA samples.  These results are inconsistent with the information provided by 
the supplier [Table 3.5.1] as BEA is a ‘high silica’ zeolite with a Si:Al ratio ≥10 [180].  BEAs’s 
lower Si:Al ratio results indicates the presence of some defect silanol (Si(OH)x) groups in the 
BEA sample.  As the ratio of tetrahedral silicon and aluminium in the zeolite framework can be 
directly calculated from the line intensities in a 29-Si MAS NMR by the following equation 
assuming that the Al-Al avoidance rule of Lowenstein is obeyed and Si(OH)x signals are not 
included in the bands: 
 
(Si:Al)NMR = ∑𝐼𝑆𝑖(𝑛𝐴𝑙)/ ∑
𝑛
4
𝐼𝑆𝑖(𝑛𝐴𝑙) summation is from n = 0 to n = 4 
 
Equation 3.1 – Equation for SI:Al ratio 
 
 
 
The resulting Si:Al may strongly under estimate the actual Si:Al ratio as defect sites (Si(OH)x 
groups) are generally present in the zeolite framework [181]   
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With clinoptilolite having the lower Si:Al ratio it is expected that clinoptilolite’s framework 
would contain more cations.  As a result, clinoptilolite should perform better at adsorbing 
pharmaceuticals with polar functional groups.  Consequently, the HPLC results show the 
clinoptilolite samples to have a higher percentage drug uptake for both acetaminophen and 
Na-ibuprofen [Table 3.1.1] [Table 3.2.1] [Table 3.3.3 – 3.3.6].  Therefore, it is believed that 
adsorption results are influenced by the absorbents pore shape and size, as well as, the 
number of cations present.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.6 BET Results 
 
118 | P a g e  
 
If the drug was adsorbed into the zeolites pore it is thought the pores volume would decrease.  
Therefore, BET analysis was performed on the two clinoptilolites, before and after drug 
adsorption, in order to determine if the drug is in the pore by comparing the pore volumes 
[Table 3.6.1 - Table 3.6.2].  Dehydration was performed at 100C under vacuum, rather than 
300C, so the majority of water is removed and to prevent the breakdown of the  drug 
adsorbed.     
Table 3.6.1 – BET results showing the micropore volume (cm
3
/g) for the following samples: 1) Moroccan 
clinoptilolite standard, 2) Moroccan clinoptilolite adsorbed with acetaminophen and 2) Moroccan 
clinoptilolite adsorbed with Na-ibuprofen 
 
Moroccan Clinoptilolite Sample: Micropore Volume (cm3/g) 
1) Standard 0.003 
2) Adsorbed with Acetaminophen 0.001 
3) Adsorbed with Na-Ibuprofen 0.002 
 
 
Table 3.6.2 –BET results showing the micropore volume (cm
3
/g) for the following samples: 1) Japanese 
clinoptilolite standard, 2) Japanese clinoptilolite adsorbed with acetaminophen and 2) Japanese 
clinoptilolite adsorbed with Na-ibuprofen 
 
Japanese Clinoptilolite Sample: Micropore Volume (cm3/g) 
1) Standard 0.003 
2) Adsorbed with Acetaminophen 0.001 
3) Adsorbed with Na-Ibuprofen 0.002 
 
 
From the BET results obtained [Table 3.6.1 - Table 3.6.2] it is believed that that cations found 
in clinoptilolites pores binds to functional groups of acetaminophen and Na-ibuprofen.  As 
both Moroccan and Japanese clinoptilolite samples have an approximate pore volume of 0.003 
cm3 /g [Table 3.6.1 - Table 3.6.2], which decrease in size after drug uptake.  For both 
clinoptilolite samples, the pore volume is smallest after adsorption of acetaminophen with an 
approximate size of 0.001 cm3/g [Table 3.6.1 - Table 3.6.2].   
 
The pore volume also decreases after adsorption of Na-ibuprofen, for both samples, with 
approximate volume of 0.002 cm3/g [Table 3.6.1 - Table 3.6.2].  From the HPLC results 
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obtained, it was initially thought the smaller pore volumes would have been exhibited by the 
clinoptilolite samples absorbed with Na-ibuprofen, due to the HPLC results showing both 
clinoptilolite samples to adsorb more Na-ibuprofen [Table 3.1.1] [Table 3.2.1] [Table 3.3.3 – 
Table 3.3.6].  However, as this is not the case, it is now thought that the larger pore volume is 
due to the adsorption of Na-ibuprofen and the formation of degradation products, such as the 
propanoate ion.  However, we do not know if the products are degrading in the water or if 
clinoptilolite is enhancing the degradation.  None the less, the smaller pore volume after 
adsorption indicates clinoptilolite adsorbs acetaminophen and Na-ibuprofen into its pores. 
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Chapter 4: Conclusion and Future work 
 
This work focused on the adsorption of the pharmaceuticals; acetaminophen and Na-
ibuprofen by clinoptilolite and zeolite BEA.  The study included how the adsorption capacity 
was effected by cation-exchange and from the altered elemental composition of natural 
clinoptilolite that was attained from different geographical locations.  
The results indicated that clinoptilolite was more efficient in the removal of the analgesics in 
question.  However, it should be highlighted that both analgesics appeared to be absorbed 
into clinoptilolites pores, even though the drugs dimensions appear to be larger than the pore 
dimensions.  In contrary, BEA achieved lower adsorption results even though the dimensions 
of its pores appear to be suitable for adsorption.  These results are similar to Martucci et al. 
[182] who investigated the absorbance of three antibiotics; erythromycin (ERY), 
carbamazepine (CBZ) and levofloxacin (FLX) by using zeolite Y, mordenite (MOR) and ZSM-5.  
They expected little to no adsorption of ERY by zeolite Y as the drug dimensions appeared to 
be too large to pass through the zeolites 12-ring windows that are restricting access to the 
large cage.  However, zeolite Y achieved the best adsorption results for ERY, whereas, the 
zeolites MOR and ZSM-5 did not absorb CBZ, even though both materials had larger and more 
suitable channel dimensions.  
The modified zeolites by cation-exchange showed different adsorption capacities in 
comparison to the initial zeolite.  More importantly, the results obtained show how the 
presence of different cations can adjust or even be used to tailor specific adsorptions.  It was 
found that the addition of Cu(II) cations to natural clinoptilolite specifically enhanced the 
adsorption of Na-ibuprofen.  The differences in ion-exchange selectivity has prompted the idea 
of further investigations with different cations to find the optimum modification.  Future work 
could include the sorption of the metallic cations: Zn(II), Mn(II) and Ni(II). Rakic ́ et al. [155] 
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sorbed these metallic cations into clinoptilolite to enhance adsorption of salicylic acid, 
acetysalicyclic acid and atenolol, as the metal cations form stable complexes with N- and O- 
donor groups present in their chosen pharmaceuticals.  As both Na-ibuprofen and 
acetaminophen contain N- and O- donor groups it would be interesting if we could achieve 
similar adsorption results.     
Furthermore, the results also proved that drug adsorption can be altered with the use of a 
natural zeolite attained from different geographical locations.  It was found that the different 
elemental compositions of the two clinoptilolite effected the amount of pharmaceutical 
adsorbed.  As clinoptilolite from Morocco achieved overall highest adsorptions.  Future work 
could focus on investigating the adsorption capacities of clinoptilolite attained from different 
geographical locations, such as; Australia or Turkey.  As the clinoptilolite used to adsorb 
nuclear waste in Sellafield, England, is obtained from one specific mine due to this particular 
clinoptilolite having a high selectivity towards Cs+ ions. 
The overall results obtained show that both clinoptilolite and BEA can be used to remove the 
investigated analgesics by adsorption.  However, as clinoptilolite achieved the highest 
adsorption results it would be of interest to see if it had similar adsorption affinities towards 
other drugs such as naproxen and diclofenac.  A recent study [183] used clinoptilolite from 
California as a surface modified natural zeolite as a carrier for sustained diclofenac release.  
The study concluded that clinoptilolite made a very versatile drug carrier since molecules with 
different chemical properties can be potentially loaded in or on the zeolite.  As clinoptilolite 
surface is easily modified, it broadens the range of ways in which the material can be applied, 
therefore, the research group is continuing their focus on the pharmaceutical application of 
clinoptilolite. 
Additionally, the work presented here could also further investigate the location of the drugs 
after adsorption.  As it is not clear whether the drugs are located at the zeolites surface or 
inside the pores.   Particularly, as clinoptilolite has showed to form interactions with 
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pharmaceuticals at its surface [183], as well as, inside its pores [155].  Extended X-ray 
adsorption fine structure (EXAFS) spectroscopy could potentially be used to identify the 
location of the drug after adsorption, due to EXAFS analysing specific local areas only.  Future 
work would specifically look at the local area surrounding the Cu cations before and after 
adsorption, due Cu-exchanged Clinoptilolite exhibited the highest drug adsorption.  Analysis by 
EXAFS could determine if the drug is forming a stable complex with Cu cations present by 
looking at changes exhibited by the arrangement of atoms surrounding the cation before and 
after adsorption. 
Further characterisation of the zeolites content could be done by the physiochemical 
technique thermogravimetric analysis (TGA).  TGA is an analytical technique in which the effect 
of heat on the mass of a sample with time is studied to obtain quantitative information.  TGA 
can obtain information about various parameters, namely mass, enthalpy, magnetic and 
electrical properties.  Thermal events are usually recorded by observing the change in the 
thermal property as the temperature is varied to give a thermal analysis curve or a 
thermogram.  The thermal events which can lead to some important quantitative information 
can be melting, phase transition, decomposition and glass transition.  Thermogravimetry, in 
particular, would be able to provide the change in mass of the sample as the temperature is 
varied.  When the sample is heated from ambient to 1000C, under an atmosphere of O2 or N2, 
characteristic weight losses can be obtained which may yield important information regarding 
the zeolites uptake of the drug.  It is expected that the thermogram of the pure drug to be a 
different shape when compared to the thermogram of the drug loaded zeolite.  This change 
would show the presence of drug in confined environments verses the free drug [184]. 
Lastly, the BET results obtained have shown the pore volume of the clinoptilolite absorbed 
with acetaminophen to be smaller than clinoptilolite absorbed with Na-ibuprofen.  This is 
particularly interesting as HPLC results have shown clinoptilolite to absorb more Na-ibuprofen, 
therefore, it was initially thought that the pore volume of clinoptilolite absorbed with Na-
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ibuprofen would have the smaller volume.  As this is not the case, future work would involve 
the study of the potential degradation products of Na-ibuprofen and if clinoptilolite is 
catalysing the degradation upon adsorption.  It is thought that clinoptilolite is forming 
complexes with degradation products as it is conveying a larger pore volume.  Furthermore, 
one of the degradation products could be a propanoate ion, as it was found to have matching 
diffraction peaks to the “clinoptilolite Cu-exchanged absorbed with Na-ibuprofen” sample.  To 
identify other possible degradation products future work could include high performance 
liquid chromatography, in conjunction with a mass spectrometer (HPLC-MS) analyse of 
adsorption experiment samples taken at variable time intervals.  By identifying the 
degradation products it would be possible to determine a degradation mechanism. 
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